AOP,ID,s.name,Stressor
Inhibition of JAK3 leading to impairment of T-Cell Dependent Antibody Response,315,RB1,[CHEBI:33322]
Inhibition of JAK3 leading to impairment of T-Cell Dependent Antibody Response,315,4-aminopiperidine,[mesh:C481395]
Inhibition of JAK3 leading to impairment of T-Cell Dependent Antibody Response,315,PF-06651600,[mesh:C000614924]
Inhibition of JAK3 leading to impairment of T-Cell Dependent Antibody Response,315,1792180-81-4,[mesh:C539455]
Receptor mediated endocytosis and lysosomal overload leading to kidney toxicity,257,metallothionine,[mesh:D005278]
Receptor mediated endocytosis and lysosomal overload leading to kidney toxicity,257,Oxygen,[mesh:D010100]
Receptor mediated endocytosis and lysosomal overload leading to kidney toxicity,257,aminoglycosides,[mesh:D000617]
Receptor mediated endocytosis and lysosomal overload leading to kidney toxicity,257,polymyxins,[mesh:D011113]
Receptor mediated endocytosis and lysosomal overload leading to kidney toxicity,257,Cd,[CHEBI:22977]
Aromatase induction leading to estrogen receptor alpha activation via increased estradiol,561,Estrogen,[mesh:D004967]
Aromatase induction leading to estrogen receptor alpha activation via increased estradiol,561,estradiol,[CHEBI:16469]
CYP2E1 activation and formation of protein adducts leading to neurodegeneration,260,ethanol,[mesh:D000431]
CYP2E1 activation and formation of protein adducts leading to neurodegeneration,260,Acetaldehyde,[mesh:D000079]
CYP2E1 activation and formation of protein adducts leading to neurodegeneration,260,MDA,[CHEBI:32506]
CYP2E1 activation and formation of protein adducts leading to neurodegeneration,260,4-hydroxynonenal,[CHEBI:58968]
"Decreased, GnRH pulsatility/release leading to estradiol availability, increased via impaired ovulation",566,Estrogen,[mesh:D004967]
"Decreased, GnRH pulsatility/release leading to estradiol availability, increased via impaired ovulation",566,Androgen,[mesh:D000728]
"Decreased, GnRH pulsatility/release leading to estradiol availability, increased via impaired ovulation",566,estradiol,[CHEBI:16469]
"Decreased, GnRH pulsatility/release leading to estradiol availability, increased via impaired ovulation",566,GABA,[mesh:D005680]
"Decreased, GnRH pulsatility/release leading to estradiol availability, increased via impaired ovulation",566,PVC,[mesh:D011143]
"Decreased, GnRH pulsatility/release leading to estradiol availability, increased via impaired ovulation",566,P4,[CHEBI:35898]
"Decreased, GnRH pulsatility/release leading to estradiol availability, increased via impaired ovulation",566,steroid,[mesh:D013256]
"Decreased, GnRH pulsatility/release leading to estradiol availability, increased via impaired ovulation",566,progesterone,[mesh:D011374]
Renal protein alkylation leading to kidney toxicity,258,trichloroethylene,[mesh:D014241]
Renal protein alkylation leading to kidney toxicity,258,tetrachloroethylene,[mesh:D013750]
Renal protein alkylation leading to kidney toxicity,258,hydroquinone,[mesh:C031927]
Renal protein alkylation leading to kidney toxicity,258,bromobenzene,[mesh:C032036]
Renal protein alkylation leading to kidney toxicity,258,cephalosporins,[mesh:D002511]
Renal protein alkylation leading to kidney toxicity,258,4-aminophenol,[mesh:C026729]
Renal protein alkylation leading to kidney toxicity,258,"N-(3,5-dichlorophenyl)succinimide",[mesh:C007352]
Renal protein alkylation leading to kidney toxicity,258,creatinine,[mesh:D003404]
Renal protein alkylation leading to kidney toxicity,258,urea,[mesh:D014508]
Renal protein alkylation leading to kidney toxicity,258,nitrogen,[mesh:D009584]
Renal protein alkylation leading to kidney toxicity,258,haloalkenes,[CHEBI:5610]
Renal protein alkylation leading to kidney toxicity,258,ATP,[CHEBI:30616]
Renal protein alkylation leading to kidney toxicity,258,"hexachloro-1,3-butadiene",[mesh:C001335]
Renal protein alkylation leading to kidney toxicity,258,chloroform,[mesh:D002725]
Renal protein alkylation leading to kidney toxicity,258,quinones,[mesh:D011809]
"17β-Hydroxysteroid dehydrogenase 2, inhibition leading to activation, estrogen receptor alpha",565,Estrogen,[mesh:D004967]
"17β-Hydroxysteroid dehydrogenase 2, inhibition leading to activation, estrogen receptor alpha",565,17-Hydroxysteroid,[CHEBI:36838]
Binding of SARS-CoV-2 to ACE2 receptor leading to acute respiratory distress associated mortality,320,serine,[mesh:D012694]
HCN Channel Inhibition leading to Arrhythmias,562,nucleotides,[mesh:D009711]
HCN Channel Inhibition leading to Arrhythmias,562,ivabradine,[mesh:D000077550]
HCN Channel Inhibition leading to Arrhythmias,562,zatebradine,[mesh:C043636]
Binding to ACE2 leading to lung fibrosis,319,Oxygen,[mesh:D010100]
Uncoupling of oxidative phosphorylation leading to growth inhibition via ATP depletion associated cell death,264,ATP,[CHEBI:30616]
Uncoupling of oxidative phosphorylation leading to growth inhibition via ATP depletion associated cell death,264,adenosine triphosphate,[mesh:D000255]
Uncoupling of oxidative phosphorylation leading to growth inhibition via ATP depletion associated cell death,264,adenosine diphosphate,[mesh:D000244]
Uncoupling of oxidative phosphorylation leading to growth inhibition via ATP depletion associated cell death,264,ADP,[CHEBI:73342]
Uncoupling of oxidative phosphorylation leading to growth inhibition via increased cytosolic calcium,265,ATP,[CHEBI:30616]
Uncoupling of oxidative phosphorylation leading to growth inhibition via increased cytosolic calcium,265,Calcium,[mesh:D002118]
DBDPE-induced inhibition of mitochondrial complex Ⅰ leading to population decline via neurotoxicity and metabotoxicity.,564,polybrominated diphenyl ethers,[mesh:D055768]
DBDPE-induced inhibition of mitochondrial complex Ⅰ leading to population decline via neurotoxicity and metabotoxicity.,564,ATP,[CHEBI:30616]
DBDPE-induced inhibition of mitochondrial complex Ⅰ leading to population decline via neurotoxicity and metabotoxicity.,564,NAD+,[CHEBI:15846]
DBDPE-induced inhibition of mitochondrial complex Ⅰ leading to population decline via neurotoxicity and metabotoxicity.,564,DBDPE,[mesh:D015123]
DBDPE-induced inhibition of mitochondrial complex Ⅰ leading to population decline via neurotoxicity and metabotoxicity.,564,Decabromodiphenyl ethane,[mesh:C491509]
DBDPE-induced inhibition of mitochondrial complex Ⅰ leading to population decline via neurotoxicity and metabotoxicity.,564,nicotinamide riboside,[CHEBI:15927]
Excessive reactive oxygen species leading to growth inhibition via oxidative DNA damage and cell death,324,Oxygen,[mesh:D010100]
Excessive reactive oxygen species leading to growth inhibition via oxidative DNA damage and cell death,324,superoxide,[mesh:D013481]
Excessive reactive oxygen species leading to growth inhibition via oxidative DNA damage and cell death,324,hydrogen peroxide,[mesh:D006861]
Excessive reactive oxygen species leading to growth inhibition via oxidative DNA damage and cell death,324,adenine,[mesh:D000225]
Excessive reactive oxygen species leading to growth inhibition via oxidative DNA damage and cell death,324,8-oxoG,[mesh:C046215]
Excessive reactive oxygen species leading to growth inhibition via oxidative DNA damage and cell death,324,8-oxoguanine,[CHEBI:44605]
Excessive reactive oxygen species leading to growth inhibition via oxidative DNA damage and cell death,324,hydroxyl,[mesh:D017665]
Uncoupling of oxidative phosphorylation leading to growth inhibition via decreased Na-K ATPase activity,266,Oxygen,[mesh:D010100]
Uncoupling of oxidative phosphorylation leading to growth inhibition via decreased Na-K ATPase activity,266,Na+,[CHEBI:29101]
Uncoupling of oxidative phosphorylation leading to growth inhibition via decreased Na-K ATPase activity,266,K+,[CHEBI:29103]
L-type calcium channel blockade leading to heart failure via decrease in cardiac contractility,261,potassium,[mesh:D011188]
L-type calcium channel blockade leading to heart failure via decrease in cardiac contractility,261,Calcium,[mesh:D002118]
Excessive reactive oxygen species leading to growth inhibition via lipid peroxidation and cell death,325,Oxygen,[mesh:D010100]
Excessive reactive oxygen species leading to growth inhibition via lipid peroxidation and cell death,325,superoxide,[mesh:D013481]
Excessive reactive oxygen species leading to growth inhibition via lipid peroxidation and cell death,325,hydrogen peroxide,[mesh:D006861]
Excessive reactive oxygen species leading to growth inhibition via lipid peroxidation and cell death,325,adenine,[mesh:D000225]
Excessive reactive oxygen species leading to growth inhibition via lipid peroxidation and cell death,325,8-oxoG,[mesh:C046215]
Excessive reactive oxygen species leading to growth inhibition via lipid peroxidation and cell death,325,8-oxoguanine,[CHEBI:44605]
Excessive reactive oxygen species leading to growth inhibition via lipid peroxidation and cell death,325,hydroxyl,[mesh:D017665]
Decreased testosterone synthesis leading to hypospadias in male (mammalian) offspring,570,testosterone,[mesh:D013739]
L-type calcium channel blockade leading to the disruption of cardiac electrophysiology,262,Calcium,[mesh:D002118]
PPARalpha Agonism Leading to Decreased Viable Offspring via Decreased 11-Ketotestosterone,323,fatty acid,[mesh:D005227]
PPARalpha Agonism Leading to Decreased Viable Offspring via Decreased 11-Ketotestosterone,323,11-KT,[mesh:C016531]
PPARalpha Agonism Leading to Decreased Viable Offspring via Decreased 11-Ketotestosterone,323,per- and polyfluoroalkyl,[CHEBI:60582]
PPARalpha Agonism Leading to Decreased Viable Offspring via Decreased 11-Ketotestosterone,323,PFAS,[CHEBI:53371]
PPARalpha Agonism Leading to Decreased Viable Offspring via Decreased 11-Ketotestosterone,323,11-Ketotestosterone,[mesh:C003600]
PPARalpha Agonism Leading to Decreased Viable Offspring via Decreased 11-Ketotestosterone,323,cholesterol,[mesh:D002784]
Uncoupling of oxidative phosphorylation leading to  growth inhibition via decreased cell proliferation,263,ATP,[CHEBI:30616]
Uncoupling of oxidative phosphorylation leading to  growth inhibition via decreased cell proliferation,263,adenosine triphosphate,[mesh:D000255]
Uncoupling of oxidative phosphorylation leading to  growth inhibition via decreased cell proliferation,263,adenosine diphosphate,[mesh:D000244]
Uncoupling of oxidative phosphorylation leading to  growth inhibition via decreased cell proliferation,263,ADP,[CHEBI:73342]
Decreased DNA methylation of FAM50B/PTCHD3 leading to IQ loss of children via PI3K-Akt pathway,569,arsenic,[mesh:D001151]
Decreased DNA methylation of FAM50B/PTCHD3 leading to IQ loss of children via PI3K-Akt pathway,569,gasoline,[mesh:D005742]
Mitochondrial complex inhibition leading to liver injury,273,ATP,[CHEBI:30616]
"Binding of plastoquinone B leading to decrease, population growth rate via decrease, photosystem II efficiency",567,plastoquinone B,[CHEBI:28377]
Glucocorticoid Receptor Agonism Leading to Impaired Fin Regeneration,334,Estrogen,[mesh:D004967]
Glucocorticoid Receptor Agonism Leading to Impaired Fin Regeneration,334,steroid,[mesh:D013256]
"Inhibition, 5-hydroxytryptamine transporter (5-HTT; SERT) leads to Inhibition, Feeding",568,dopamine,[mesh:D004298]
"Inhibition, 5-hydroxytryptamine transporter (5-HTT; SERT) leads to Inhibition, Feeding",568,GABA,[mesh:D005680]
"Inhibition, 5-hydroxytryptamine transporter (5-HTT; SERT) leads to Inhibition, Feeding",568,chloride,[CHEBI:15767]
"Inhibition, 5-hydroxytryptamine transporter (5-HTT; SERT) leads to Inhibition, Feeding",568,serotonin,[CHEBI:350546]
"Inhibition, 5-hydroxytryptamine transporter (5-HTT; SERT) leads to Inhibition, Feeding",568,Sodium,[mesh:D012964]
"Inhibition, 5-hydroxytryptamine transporter (5-HTT; SERT) leads to Inhibition, Feeding",568,potassium,[mesh:D011188]
"Inhibition, 5-hydroxytryptamine transporter (5-HTT; SERT) leads to Inhibition, Feeding",568,5-hydroxytryptamine,[mesh:D012701]
"Inhibition, 5-hydroxytryptamine transporter (5-HTT; SERT) leads to Inhibition, Feeding",568,norepinephrine,[CHEBI:33569]
Excessive reactive oxygen species leading to growth inhibition via oxidative DNA damage and reduced cell proliferation,331,Oxygen,[mesh:D010100]
Inhibition of thyroid peroxidase leading to impaired fertility in fish,271,VTG,[mesh:D020888]
Excessive reactive oxygen species leading to growth inhibition via lipid peroxidation and reduced cell proliferation,332,Oxygen,[mesh:D010100]
Elevated ATP demand for detoxification and repair mechanisms leading to impaired locomotor activity,270,Oxygen,[mesh:D010100]
Elevated ATP demand for detoxification and repair mechanisms leading to impaired locomotor activity,270,ATP,[CHEBI:30616]
Excessive reactive oxygen species leading to growth inhibition via uncoupling of oxidative phosphorylation,333,Oxygen,[mesh:D010100]
"Inhibition, cytochrome oxidase leads to Loss of olfactory function",574,ATP,[CHEBI:30616]
"Inhibition, cytochrome oxidase leads to Loss of olfactory function",574,hydrogen sulfide,[mesh:D006862]
"Inhibition, cytochrome oxidase leads to Loss of olfactory function",574,potassium cyanide,[mesh:D011190]
"Inhibition, cytochrome oxidase leads to Loss of olfactory function",574,sodium azide,[mesh:D019810]
"Inhibition, cytochrome oxidase leads to Increased, pulmonary edema",573,ATP,[CHEBI:30616]
"Inhibition, cytochrome oxidase leads to Increased, pulmonary edema",573,hydrogen sulfide,[mesh:D006862]
"Inhibition, cytochrome oxidase leads to Increased, pulmonary edema",573,potassium cyanide,[mesh:D011190]
"Inhibition, cytochrome oxidase leads to Increased, pulmonary edema",573,sodium azide,[mesh:D019810]
BMP4 Suppression Disrupting Cytoskeletal Remodeling Leading to Neural Tube Closure Defects,572,neonicotinoid,[mesh:D000073943]
BMP4 Suppression Disrupting Cytoskeletal Remodeling Leading to Neural Tube Closure Defects,572,imidacloprid,[mesh:C082359]
Excessive reactive oxygen species production leading to mortality (1),327,Oxygen,[mesh:D010100]
Uncoupling of oxidative phosphorylation leading to growth inhibition via glucose depletion,267,Oxygen,[mesh:D010100]
Uncoupling of oxidative phosphorylation leading to growth inhibition via glucose depletion,267,glucose,[CHEBI:42758]
Excessive reactive oxygen species production leading to mortality (2),328,Oxygen,[mesh:D010100]
Uncoupling of oxidative phosphorylation leading to growth inhibition via mitochondrial swelling,268,Oxygen,[mesh:D010100]
Excessive reactive oxygen species production leading to mortality (3),329,Oxygen,[mesh:D010100]
Transthyretin disruption in developing fish leading to projected decline in fish population,579,PFOS,[CHEBI:39421]
Transthyretin disruption in developing fish leading to projected decline in fish population,579,polybrominated diphenyl ethers,[mesh:D055768]
Transthyretin disruption in developing fish leading to projected decline in fish population,579,TBBPA,[mesh:C020806]
Transthyretin disruption in developing fish leading to projected decline in fish population,579,polychlorinated biphenyls,[CHEBI:53156]
Transthyretin disruption in developing fish leading to projected decline in fish population,579,PFAS,[CHEBI:53371]
Elevated ATP demand for detoxification and repair mechanisms leading to impaired growth and development,269,ATP,[CHEBI:30616]
Excessive reactive oxygen species production leading to mortality (4),330,Oxygen,[mesh:D010100]
Decreased testosterone synthesis leading to increased nipple retention (NR) in male (rodent) offspring,575,testosterone,[mesh:D013739]
Excessive reactive oxygen species leading to growth inhibition via protein oxidation and cell death,326,Oxygen,[mesh:D010100]
Excessive reactive oxygen species leading to growth inhibition via protein oxidation and cell death,326,superoxide,[mesh:D013481]
Excessive reactive oxygen species leading to growth inhibition via protein oxidation and cell death,326,hydrogen peroxide,[mesh:D006861]
Excessive reactive oxygen species leading to growth inhibition via protein oxidation and cell death,326,adenine,[mesh:D000225]
Excessive reactive oxygen species leading to growth inhibition via protein oxidation and cell death,326,8-oxoG,[mesh:C046215]
Excessive reactive oxygen species leading to growth inhibition via protein oxidation and cell death,326,8-oxoguanine,[CHEBI:44605]
Excessive reactive oxygen species leading to growth inhibition via protein oxidation and cell death,326,hydroxyl,[mesh:D017665]
AOP for urothelial carcinogenesis due to chemical cytotoxicity by mitochondrial impairment,335,diuron,[mesh:D004237]
Inhibition of complex I of the electron transport chain leading to chemical induced Fanconi syndrome,276,ATP,[CHEBI:30616]
Inhibition of complex I of the electron transport chain leading to chemical induced Fanconi syndrome,276,Sodium,[mesh:D012964]
Inhibition of complex I of the electron transport chain leading to chemical induced Fanconi syndrome,276,potassium,[mesh:D011188]
Histone deacetylase inhibition leads to impeded craniofacial development,274,valproic acid,[CHEBI:39867]
Binding of electrophilic chemicals to SH(thiol)-group of proteins and /or to seleno-proteins involved in protection against oxidative stress leads to chronic kidney disease,284,SH,[CHEBI:73651]
Binding of electrophilic chemicals to SH(thiol)-group of proteins and /or to seleno-proteins involved in protection against oxidative stress leads to chronic kidney disease,284,thiol,[mesh:D013438]
Binding of electrophilic chemicals to SH(thiol)-group of proteins and /or to seleno-proteins involved in protection against oxidative stress leads to chronic kidney disease,284,seleno,[CHEBI:16503]
Binding of electrophilic chemicals to SH(thiol)-group of proteins and /or to seleno-proteins involved in protection against oxidative stress leads to chronic kidney disease,284,(,[mesh:C060185]
Androgen receptor (AR) antagonism leading to nipple retention (NR) in male (mammalian) offspring,344,Androgen,[mesh:D000728]
Androgen receptor (AR) antagonism leading to nipple retention (NR) in male (mammalian) offspring,344,5-alpha-dihydrotestosterone,[mesh:D013196]
Androgen receptor (AR) antagonism leading to nipple retention (NR) in male (mammalian) offspring,344,testosterone,[mesh:D013739]
Inhibition of N-linked glycosylation leads to liver injury,285,N,[CHEBI:25555]
Androgen receptor (AR) antagonism leading to decreased fertility in females,345,Androgen,[mesh:D000728]
α-diketone-induced bronchiolitis obliterans,280,arginine,[mesh:D001120]
α-diketone-induced bronchiolitis obliterans,280,diacetyl,[mesh:D003931]
α-diketone-induced bronchiolitis obliterans,280,diketone,[CHEBI:46640]
S-adenosylmethionine depletion leading to population decline (1),342,S-adenosylmethionine,[CHEBI:67040]
Acetylcholinesterase Inhibition Leading to Neurodegeneration,281,acetylcholine,[mesh:D000109]
Acetylcholinesterase Inhibition Leading to Neurodegeneration,281,Carbamate,[CHEBI:28616]
Acetylcholinesterase Inhibition Leading to Neurodegeneration,281,Calcium,[mesh:D002118]
Acetylcholinesterase Inhibition Leading to Neurodegeneration,281,organophosphate,[mesh:D010755]
L-type calcium channel blockade leading to hypotension,283,Calcium,[mesh:D002118]
Inhibition of 11β-hydroxylase leading to decresed population trajectory,349,testosterone,[mesh:D013739]
Inhibition of 11β-hydroxylase leading to decresed population trajectory,349,11 beta -hydroxytestosterone,[mesh:C037914]
Inhibition of 11β-hydroxylase leading to decresed population trajectory,349,eomidate,[mesh:C014539]
Inhibition of 11β-hydroxylase leading to decresed population trajectory,349,11-deoxycortisol,[mesh:D003350]
Inhibition of 11β-hydroxylase leading to decresed population trajectory,349,lysodren,[mesh:D008939]
Inhibition of 11β-hydroxylase leading to decresed population trajectory,349,11-KT,[mesh:C016531]
Inhibition of 11β-hydroxylase leading to decresed population trajectory,349,metyrapone,[mesh:D008797]
Inhibition of 11β-hydroxylase leading to decresed population trajectory,349,cortisol,[mesh:D006854]
Aromatase inhibition leads to male-biased sex ratio via impacts on gonad differentiation,346,Estrogen,[mesh:D004967]
Aromatase inhibition leads to male-biased sex ratio via impacts on gonad differentiation,346,C19,[CHEBI:32928]
Aromatase inhibition leads to male-biased sex ratio via impacts on gonad differentiation,346,C18,[mesh:D044243]
Aromatase inhibition leads to male-biased sex ratio via impacts on gonad differentiation,346,Androgen,[mesh:D000728]
Aromatase inhibition leads to male-biased sex ratio via impacts on gonad differentiation,346,testosterone,[mesh:D013739]
Aromatase inhibition leads to male-biased sex ratio via impacts on gonad differentiation,346,fadrozole,[mesh:D017316]
Aromatase inhibition leads to male-biased sex ratio via impacts on gonad differentiation,346,exemestane,[mesh:C056516]
Aromatase inhibition leads to male-biased sex ratio via impacts on gonad differentiation,346,steroid,[mesh:D013256]
Aromatase inhibition leads to male-biased sex ratio via impacts on gonad differentiation,346,17-estradiol,[CHEBI:17160]
Aromatase inhibition leads to male-biased sex ratio via impacts on gonad differentiation,346,propiconazole,[mesh:C045950]
Aromatase inhibition leads to male-biased sex ratio via impacts on gonad differentiation,346,letrozole,[mesh:D000077289]
Aromatase inhibition leads to male-biased sex ratio via impacts on gonad differentiation,346,prochloraz,[mesh:C045362]
Inhibition of 11β-Hydroxysteroid Dehydrogenase leading to decreased population trajectory,348,Androgen,[mesh:D000728]
Inhibition of 11β-Hydroxysteroid Dehydrogenase leading to decreased population trajectory,348,11-Hydroxysteroid,[CHEBI:36841]
Inhibition of 11β-Hydroxysteroid Dehydrogenase leading to decreased population trajectory,348,NAD+,[CHEBI:15846]
Inhibition of 11β-Hydroxysteroid Dehydrogenase leading to decreased population trajectory,348,cortisone,[mesh:D003348]
Inhibition of 11β-Hydroxysteroid Dehydrogenase leading to decreased population trajectory,348,11 beta -hydroxytestosterone,[mesh:C037914]
Inhibition of 11β-Hydroxysteroid Dehydrogenase leading to decreased population trajectory,348,corticosteroid,[mesh:D000305]
Inhibition of 11β-Hydroxysteroid Dehydrogenase leading to decreased population trajectory,348,11-KT,[mesh:C016531]
Inhibition of 11β-Hydroxysteroid Dehydrogenase leading to decreased population trajectory,348,cortisol,[mesh:D006854]
Inhibition of 11β-Hydroxysteroid Dehydrogenase leading to decreased population trajectory,348,11-Ketotestosterone,[mesh:C003600]
Mitochondrial ATP synthase antagonism leading to growth inhibition (1),290,ATP,[CHEBI:30616]
Inhibition of 5α-reductase leading to impaired fecundity in female fish,289,Estrogen,[mesh:D004967]
Inhibition of 5α-reductase leading to impaired fecundity in female fish,289,Androgen,[mesh:D000728]
Inhibition of 5α-reductase leading to impaired fecundity in female fish,289,5-alpha-dihydrotestosterone,[mesh:D013196]
Inhibition of 5α-reductase leading to impaired fecundity in female fish,289,testosterone,[mesh:D013739]
Inhibition of 5α-reductase leading to impaired fecundity in female fish,289,3-diol,[CHEBI:23824]
Inhibition of 5α-reductase leading to impaired fecundity in female fish,289,3-oxo-5-steroid,[CHEBI:47907]
Inhibition of 5α-reductase leading to impaired fecundity in female fish,289,3-oxo-&Delta;4-steroid,[CHEBI:47909]
Inhibition of 5α-reductase leading to impaired fecundity in female fish,289,steroid,[mesh:D013256]
Inhibition of 5α-reductase leading to impaired fecundity in female fish,289,finasteride,[mesh:D018120]
Inhibition of 5α-reductase leading to impaired fecundity in female fish,289,dutasteride,[mesh:D000068538]
Inhibition of 5α-reductase leading to impaired fecundity in female fish,289,epristeride,[mesh:C072547]
Inhibition of 5α-reductase leading to impaired fecundity in female fish,289,3-androstanediol,[CHEBI:36713]
Inhibition of 5α-reductase leading to impaired fecundity in female fish,289,17-estradiol,[CHEBI:17160]
Inhibition of 5α-reductase leading to impaired fecundity in female fish,289,androstenedione,[mesh:D000735]
Inhibition of 5α-reductase leading to impaired fecundity in female fish,289,progesterone,[mesh:D011374]
Inhibition of 5α-reductase leading to impaired fecundity in female fish,289,cortisol,[mesh:D006854]
Inhibition of 5α-reductase leading to impaired fecundity in female fish,289,aldosterone,[mesh:D000450]
"Inhibition of 17α-hydrolase/C 10,20-lyase (Cyp17A1) activity leads to birth reproductive defects (cryptorchidism) in male (mammals)",288,Androgen,[mesh:D000728]
"Inhibition of 17α-hydrolase/C 10,20-lyase (Cyp17A1) activity leads to birth reproductive defects (cryptorchidism) in male (mammals)",288,5-alpha-dihydrotestosterone,[mesh:D013196]
"Inhibition of 17α-hydrolase/C 10,20-lyase (Cyp17A1) activity leads to birth reproductive defects (cryptorchidism) in male (mammals)",288,testosterone,[mesh:D013739]
"Inhibition of 17α-hydrolase/C 10,20-lyase (Cyp17A1) activity leads to birth reproductive defects (cryptorchidism) in male (mammals)",288,17-OH-pregnenolone,[mesh:D006907]
"Inhibition of 17α-hydrolase/C 10,20-lyase (Cyp17A1) activity leads to birth reproductive defects (cryptorchidism) in male (mammals)",288,17-OH-progesterone,[CHEBI:17252]
"Inhibition of 17α-hydrolase/C 10,20-lyase (Cyp17A1) activity leads to birth reproductive defects (cryptorchidism) in male (mammals)",288,androstenediol,[mesh:D015114]
"Inhibition of 17α-hydrolase/C 10,20-lyase (Cyp17A1) activity leads to birth reproductive defects (cryptorchidism) in male (mammals)",288,dehydroepiandrosterone,[mesh:D003687]
"Inhibition of 17α-hydrolase/C 10,20-lyase (Cyp17A1) activity leads to birth reproductive defects (cryptorchidism) in male (mammals)",288,steroid,[mesh:D013256]
"Inhibition of 17α-hydrolase/C 10,20-lyase (Cyp17A1) activity leads to birth reproductive defects (cryptorchidism) in male (mammals)",288,conazoles,[CHEBI:60593]
Immune mediated hepatitis,362,acylglucuronide,[mesh:C066070]
Immune mediated hepatitis,362,diclofenac,[mesh:D004008]
Immune mediated hepatitis,362,quinone imine,[CHEBI:50193]
Thyroperoxidase inhibition leading to altered visual function via altered retinal layer structure,363,THSDCs,[CHEBI:39330]
Thyroperoxidase inhibition leading to altered visual function via altered retinal layer structure,363,thyroxine,[CHEBI:305790]
Thyroperoxidase inhibition leading to altered visual function via altered retinal layer structure,363,retinoic acid,[CHEBI:26536]
Thyroperoxidase inhibition leading to altered visual function via altered retinal layer structure,363,morpholino,[mesh:D060172]
Thyroperoxidase inhibition leading to altered visual function via altered retinal layer structure,363,triiodothyronine,[mesh:D014284]
Chitin synthase 1 inhibition leading to mortality,360,GlcNAc,[CHEBI:73685]
Chitin synthase 1 inhibition leading to mortality,360,N-acetylglucosamine,[CHEBI:59640]
Chitin synthase 1 inhibition leading to mortality,360,uridine diphosphate,[mesh:D014530]
Sulfonylureareceptor binding leading to mortality,361,Sulfonylureareceptor,[CHEBI:26831]
Inhibition of tyrosinase leads to decreased population in fish,292,L DOPA quinone,[CHEBI:57924]
Inhibition of tyrosinase leads to decreased population in fish,292,TYR,[CHEBI:46857]
Inhibition of tyrosinase leads to decreased population in fish,292,DOPAquinone,[mesh:C035157]
Cytochrome oxidase inhibition leading to increased nasal lesions,368,ATP,[CHEBI:30616]
Cytochrome oxidase inhibition leading to increased nasal lesions,368,hydrogen sulfide,[mesh:D006862]
Cytochrome oxidase inhibition leading to increased nasal lesions,368,potassium cyanide,[mesh:D011190]
Cytochrome oxidase inhibition leading to increased nasal lesions,368,sodium azide,[mesh:D019810]
Inhibition of retinaldehyde dehydrogenase leads to population decline,297,4-biphenyl carboxylic acid,[CHEBI:31597]
Inhibition of retinaldehyde dehydrogenase leads to population decline,297,Bisdiamine,[mesh:C002491]
Inhibition of retinaldehyde dehydrogenase leads to population decline,297,Nitrofen,[mesh:C007350]
Inhibition of retinaldehyde dehydrogenase leads to population decline,297,retinol,[mesh:D014801]
Inhibition of retinaldehyde dehydrogenase leads to population decline,297,retinoic acid,[CHEBI:26536]
Inhibition of retinaldehyde dehydrogenase leads to population decline,297,RA,[CHEBI:33325]
Inhibition of retinaldehyde dehydrogenase leads to population decline,297,Diethylaminobenzaldehyde,[mesh:C055506]
Inhibition of retinaldehyde dehydrogenase leads to population decline,297,retinoid,[CHEBI:4913]
Inhibition of retinaldehyde dehydrogenase leads to population decline,297,Paclobutrazol,[mesh:C053370]
Inhibition of retinaldehyde dehydrogenase leads to population decline,297,retinaldehyde,[mesh:D012172]
Inhibition of retinaldehyde dehydrogenase leads to population decline,297,Disulphiram,[mesh:D004221]
Inhibition of retinaldehyde dehydrogenase leads to population decline,297,Citral,[CHEBI:23316]
Increase in reactive oxygen species (ROS) leading to human treatment-resistant gastric cancer via chronic ROS,298,Oxygen,[mesh:D010100]
Androgen receptor antagonism leading to testicular cancer,372,Androgen,[mesh:D000728]
Decreased testosterone synthesis leading to short anogenital distance (AGD) in male (mammalian) offspring,307,Androgen,[mesh:D000728]
Decreased testosterone synthesis leading to short anogenital distance (AGD) in male (mammalian) offspring,307,5-alpha-dihydrotestosterone,[mesh:D013196]
Decreased testosterone synthesis leading to short anogenital distance (AGD) in male (mammalian) offspring,307,testosterone,[mesh:D013739]
Decreased testosterone synthesis leading to short anogenital distance (AGD) in male (mammalian) offspring,307,cholesterol,[mesh:D002784]
Luteinizing hormone receptor antagonism leading to reproductive dysfunction,309,pregnenolone,[mesh:D011284]
Luteinizing hormone receptor antagonism leading to reproductive dysfunction,309,progesterone,[mesh:D011374]
Luteinizing hormone receptor antagonism leading to reproductive dysfunction,309,cholesterol,[mesh:D002784]
Aryl hydrocarbon receptor activation leading to impaired lung function through AHR-ARNT toxicity pathway,418,aryl hydrocarbon,[mesh:D006841]
5α-reductase inhibition leading to short anogenital distance (AGD) in male (mammalian) offspring,305,Androgen,[mesh:D000728]
5α-reductase inhibition leading to short anogenital distance (AGD) in male (mammalian) offspring,305,5-alpha-dihydrotestosterone,[mesh:D013196]
5α-reductase inhibition leading to short anogenital distance (AGD) in male (mammalian) offspring,305,testosterone,[mesh:D013739]
Androgen receptor (AR) antagonism leading to short anogenital distance (AGD) in male (mammalian) offspring,306,Androgen,[mesh:D000728]
Androgen receptor (AR) antagonism leading to short anogenital distance (AGD) in male (mammalian) offspring,306,5-alpha-dihydrotestosterone,[mesh:D013196]
Androgen receptor (AR) antagonism leading to short anogenital distance (AGD) in male (mammalian) offspring,306,testosterone,[mesh:D013739]
Bisphenol A analogs induce cellular dysfunction in human trophoblast cells in a thyroid hormone receptor-dependent manner: in silico and in vitro analyses,484,Bisphenol A,[mesh:C006780]
Androgen receptor agonism leading to male-biased sex ratio,376,Androgen,[mesh:D000728]
Androgen receptor agonism leading to male-biased sex ratio,376,steroid,[mesh:D013256]
Histone deacetylase inhibition leads to neural tube defects,275,valproic acid,[CHEBI:39867]
Nicotinic acetylcholine receptor activation contributes to abnormal foraging and leads to colony death/failure 1,77,acetylcholine,[mesh:D000109]
Nicotinic acetylcholine receptor activation contributes to impaired hive thermoregulation and leads to colony loss/failure,79,acetylcholine,[mesh:D000109]
Decrease Glucose oxidase activity contributes to reduction of antiseptic in food and leads to colony loss/failure,86,glucose,[CHEBI:42758]
Nicotinic acetylcholine receptor activation contributes to accumulation of damaged mitochondrial DNA and leads to colony loss/failure,80,acetylcholine,[mesh:D000109]
Anticoagulant rodenticide inhibition of vitamin K epoxide reductase resulting coagulopathy and hemorrhage,187,vitamin K epoxide,[mesh:C016186]
Iodotyrosine deiodinase (IYD) inhibition leading to altered amphibian metamorphosis,188,diiodotyrosine,[CHEBI:15768]
Iodotyrosine deiodinase (IYD) inhibition leading to altered amphibian metamorphosis,188,polybrominated diphenyl ethers,[mesh:D055768]
Iodotyrosine deiodinase (IYD) inhibition leading to altered amphibian metamorphosis,188,iodide,[mesh:D007454]
Iodotyrosine deiodinase (IYD) inhibition leading to altered amphibian metamorphosis,188,polychlorinated biphenyls,[CHEBI:53156]
Iodotyrosine deiodinase (IYD) inhibition leading to altered amphibian metamorphosis,188,iodine,[mesh:D007455]
Iodotyrosine deiodinase (IYD) inhibition leading to altered amphibian metamorphosis,188,Iodotyrosine,[mesh:D007470]
Iodotyrosine deiodinase (IYD) inhibition leading to altered amphibian metamorphosis,188,MIT,[CHEBI:27847]
Type I iodothyronine deiodinase (DIO1) inhibition leading to altered amphibian metamorphosis,189,"5,3-triiodothyronine",[CHEBI:18258]
Type I iodothyronine deiodinase (DIO1) inhibition leading to altered amphibian metamorphosis,189,thyroid hormones,[mesh:D013963]
Type I iodothyronine deiodinase (DIO1) inhibition leading to altered amphibian metamorphosis,189,rT3,[CHEBI:11684]
Type I iodothyronine deiodinase (DIO1) inhibition leading to altered amphibian metamorphosis,189,thyroxine (T4,[mesh:D013974]
Type I iodothyronine deiodinase (DIO1) inhibition leading to altered amphibian metamorphosis,189,iodothyronine,[CHEBI:24864]
Type I iodothyronine deiodinase (DIO1) inhibition leading to altered amphibian metamorphosis,189,triiodothyronine,[mesh:D014284]
Type II iodothyronine deiodinase (DIO2) inhibition leading to altered amphibian metamorphosis,190,"5,3-triiodothyronine",[CHEBI:18258]
Type II iodothyronine deiodinase (DIO2) inhibition leading to altered amphibian metamorphosis,190,iopanoic acid,[mesh:D007480]
Type II iodothyronine deiodinase (DIO2) inhibition leading to altered amphibian metamorphosis,190,DIO2,[mesh:C081554]
Type II iodothyronine deiodinase (DIO2) inhibition leading to altered amphibian metamorphosis,190,thyroid hormones,[mesh:D013963]
Type II iodothyronine deiodinase (DIO2) inhibition leading to altered amphibian metamorphosis,190,thyroxine (T4,[mesh:D013974]
Type II iodothyronine deiodinase (DIO2) inhibition leading to altered amphibian metamorphosis,190,iodothyronine,[CHEBI:24864]
Type III iodotyrosine deiodinase (DIO3) inhibition leading to altered amphibian metamorphosis,191,DIO3,[mesh:C098044]
Type III iodotyrosine deiodinase (DIO3) inhibition leading to altered amphibian metamorphosis,191,thyroid hormones,[mesh:D013963]
Type III iodotyrosine deiodinase (DIO3) inhibition leading to altered amphibian metamorphosis,191,"3,5-triiodothyronine",[CHEBI:28774]
Type III iodotyrosine deiodinase (DIO3) inhibition leading to altered amphibian metamorphosis,191,rT3,[CHEBI:11684]
Type III iodotyrosine deiodinase (DIO3) inhibition leading to altered amphibian metamorphosis,191,thyroxine (T4,[mesh:D013974]
Type III iodotyrosine deiodinase (DIO3) inhibition leading to altered amphibian metamorphosis,191,iodothyronine,[CHEBI:24864]
Type III iodotyrosine deiodinase (DIO3) inhibition leading to altered amphibian metamorphosis,191,Iodotyrosine,[mesh:D007470]
Nicotinic acetylcholine receptor activation contributes to abnormal foraging and leads to colony loss/failure via abnormal role change within caste,88,acetylcholine,[mesh:D000109]
Antagonist binding to PPARα leading to body-weight loss,6,-hydroxybutyrate,[CHEBI:17290]
Antagonist binding to PPARα leading to body-weight loss,6,acetyl-CoA,[mesh:D000105]
Antagonist binding to PPARα leading to body-weight loss,6,ATP,[CHEBI:30616]
Antagonist binding to PPARα leading to body-weight loss,6,fatty acid,[mesh:D005227]
Antagonist binding to PPARα leading to body-weight loss,6,glucose,[CHEBI:42758]
Antagonist binding to PPARα leading to body-weight loss,6,alanine,[mesh:D000409]
Antagonist binding to PPARα leading to body-weight loss,6,glutamine,[mesh:D005973]
Nicotinic acetylcholine receptor activation contributes to abnormal roll change within the worker bee caste leading to colony loss/failure 2,90,acetylcholine,[mesh:D000109]
Aromatase (Cyp19a1) reduction leading to impaired fertility in adult female,7,steroid,[mesh:D013256]
Aromatase (Cyp19a1) reduction leading to impaired fertility in adult female,7,cholesterol,[mesh:D002784]
5-hydroxytryptamine transporter (5-HTT) inhibition leading to population increase,195,serotonin,[CHEBI:350546]
5-hydroxytryptamine transporter (5-HTT) inhibition leading to population increase,195,5-hydroxytryptamine,[mesh:D012701]
Sodium channel inhibition leading to reduced survival,91,acetylcholine,[mesh:D000109]
Sodium channel inhibition leading to reduced survival,91,Sodium,[mesh:D012964]
Sodium channel inhibition leading to reduced survival,91,Calcium,[mesh:D002118]
Sodium channel inhibition leading to reduced survival,91,tetrodotoxin,[mesh:D013779]
Volatile Organic Chemicals Activate TRPA1 Receptor to Induce Sensory Pulmonary Irritation,196,ammonia,[mesh:D000641]
Volatile Organic Chemicals Activate TRPA1 Receptor to Induce Sensory Pulmonary Irritation,196,chlorine,[mesh:D002713]
Volatile Organic Chemicals Activate TRPA1 Receptor to Induce Sensory Pulmonary Irritation,196,hydrochloric acid,[mesh:D006851]
sodium channel inhibition leading to increased predation,93,Sodium,[mesh:D012964]
Sodium channel (Nav1.1) inhibition leading to population decline,197,Sodium,[mesh:D012964]
Sodium channel inhibition leading to congenital malformations,94,Sodium,[mesh:D012964]
Binding to the picrotoxin site of ionotropic GABA receptors leading to epileptic seizures in adult brain,10,GABA,[mesh:D005680]
Binding to the picrotoxin site of ionotropic GABA receptors leading to epileptic seizures in adult brain,10,picrotoxin,[mesh:D010852]
Binding to the picrotoxin site of ionotropic GABA receptors leading to epileptic seizures in adult brain,10,chloride,[CHEBI:15767]
Binding to the picrotoxin site of ionotropic GABA receptors leading to epileptic seizures in adult brain,10,Na+,[CHEBI:29101]
Binding to the picrotoxin site of ionotropic GABA receptors leading to epileptic seizures in adult brain,10,K+,[CHEBI:29103]
Binding to the picrotoxin site of ionotropic GABA receptors leading to epileptic seizures in adult brain,10,Ca2+,[CHEBI:29108]
Binding to the picrotoxin site of ionotropic GABA receptors leading to epileptic seizures in adult brain,10,benzodiazepines,[mesh:D001569]
Binding to the picrotoxin site of ionotropic GABA receptors leading to epileptic seizures in adult brain,10,Cl,[CHEBI:30120]
Binding to the picrotoxin site of ionotropic GABA receptors leading to epileptic seizures in adult brain,10,bicuculline,[mesh:D001640]
Binding to the picrotoxin site of ionotropic GABA receptors leading to epileptic seizures in adult brain,10,barbiturates,[mesh:D001463]
Ether-a-go-go (ERG) voltage-gated potassium channel inhibition leading to reduced survival,95,potassium,[mesh:D011188]
Estrogen receptor activation leading to breast cancer,200,Estrogen,[mesh:D004967]
Estrogen receptor activation leading to breast cancer,200,testosterone,[mesh:D013739]
Axonal sodium channel modulation leading to acute mortality,96,Sodium,[mesh:D012964]
Axonal sodium channel modulation leading to acute mortality,96,pyrethroid,[CHEBI:8811]
Juvenile hormone receptor agonism leading to male offspring induction associated population decline,201,methoprene,[mesh:D008726]
Juvenile hormone receptor agonism leading to male offspring induction associated population decline,201,methyl farnesoate,[mesh:C032429]
5-hydroxytryptamine transporter (5-HTT; SERT) inhibition leading to population decline,97,acetylcholine,[mesh:D000109]
5-hydroxytryptamine transporter (5-HTT; SERT) inhibition leading to population decline,97,Ca2+,[CHEBI:29108]
5-hydroxytryptamine transporter (5-HTT; SERT) inhibition leading to population decline,97,serotonin,[CHEBI:350546]
5-hydroxytryptamine transporter (5-HTT; SERT) inhibition leading to population decline,97,sertraline,[mesh:D020280]
5-hydroxytryptamine transporter (5-HTT; SERT) inhibition leading to population decline,97,fluoxetine,[mesh:D005473]
5-hydroxytryptamine transporter (5-HTT; SERT) inhibition leading to population decline,97,5-hydroxytryptamine,[mesh:D012701]
5-hydroxytryptamine transporter (5-HTT; SERT) inhibition leading to decreased shelter seeking and increased predation,98,5-hydroxytryptamine,[mesh:D012701]
5-hydroxytryptamine transporter inhibition leading to decreased reproductive success and population decline,203,serotonin,[CHEBI:350546]
5-hydroxytryptamine transporter inhibition leading to decreased reproductive success and population decline,203,fluoxetine,[mesh:D005473]
5-hydroxytryptamine transporter inhibition leading to decreased reproductive success and population decline,203,5-hydroxytryptamine,[mesh:D012701]
Histamine (H2) receptor antagonism leading to reduced survival,99,Histamine,[CHEBI:58432]
5-hydroxytryptamine transporter inhibition leading to increased reproductive success and population increase,204,serotonin,[CHEBI:350546]
5-hydroxytryptamine transporter inhibition leading to increased reproductive success and population increase,204,fluoxetine,[mesh:D005473]
5-hydroxytryptamine transporter inhibition leading to increased reproductive success and population increase,204,5-hydroxytryptamine,[mesh:D012701]
NADPH oxidase and P38 MAPK activation leading to reproductive failure in Caenorhabditis elegans,207,NADPH,[CHEBI:57783]
NADPH oxidase and P38 MAPK activation leading to reproductive failure in Caenorhabditis elegans,207,Oxygen,[mesh:D010100]
NADPH oxidase and P38 MAPK activation leading to reproductive failure in Caenorhabditis elegans,207,Silver,[mesh:D012834]
"Upregulation of Thyroid Hormone Catabolism via Activation of Hepatic Nuclear Receptors, and Subsequent Adverse Neurodevelopmental Outcomes in Mammals",8,polychlorinated biphenyls,[CHEBI:53156]
"Upregulation of Thyroid Hormone Catabolism via Activation of Hepatic Nuclear Receptors, and Subsequent Adverse Neurodevelopmental Outcomes in Mammals",8,PHAHs,[CHEBI:53387]
"Upregulation of Thyroid Hormone Catabolism via Activation of Hepatic Nuclear Receptors, and Subsequent Adverse Neurodevelopmental Outcomes in Mammals",8,PCB,[CHEBI:47136]
Percellome Toxicogenomics Approach for AOP Building: Case study on Pentachlorophenol,11,RO8191,[mesh:C000655265]
Percellome Toxicogenomics Approach for AOP Building: Case study on Pentachlorophenol,11,imiquimod,[mesh:D000077271]
Percellome Toxicogenomics Approach for AOP Building: Case study on Pentachlorophenol,11,PCP,[CHEBI:41473]
Percellome Toxicogenomics Approach for AOP Building: Case study on Pentachlorophenol,11,pentachlorophenol,[mesh:D010416]
Activation of c-Jun N-terminal kinase (JNK) and Forkhead box O (FOXO) and reduction of WNT pathways leading to reproductive failure: Integrated multi-OMICS approach for AOP building,210,N,[CHEBI:25555]
Activation of c-Jun N-terminal kinase (JNK) and Forkhead box O (FOXO) and reduction of WNT pathways leading to reproductive failure: Integrated multi-OMICS approach for AOP building,210,graphene oxide,[mesh:C000628730]
Chronic binding of antagonist to N-methyl-D-aspartate receptors (NMDARs) during brain development leads to neurodegeneration with impairment in learning and memory in aging,12,Pb,[CHEBI:53319]
Chronic binding of antagonist to N-methyl-D-aspartate receptors (NMDARs) during brain development leads to neurodegeneration with impairment in learning and memory in aging,12,N-methyl-D-aspartate,[mesh:D016202]
Chronic binding of antagonist to N-methyl-D-aspartate receptors (NMDARs) during brain development induces impairment of learning and memory abilities,13,aspartate,[mesh:D001224]
Chronic binding of antagonist to N-methyl-D-aspartate receptors (NMDARs) during brain development induces impairment of learning and memory abilities,13,N-methyl-D,[CHEBI:31882]
Chronic binding of antagonist to N-methyl-D-aspartate receptors (NMDARs) during brain development induces impairment of learning and memory abilities,13,glutamate,[mesh:D018698]
Chronic binding of antagonist to N-methyl-D-aspartate receptors (NMDARs) during brain development induces impairment of learning and memory abilities,13,Pb2+,[CHEBI:49807]
Chronic binding of antagonist to N-methyl-D-aspartate receptors (NMDARs) during brain development induces impairment of learning and memory abilities,13,N-methyl-D-aspartate,[mesh:D016202]
Histone deacetylase inhibition leading to testicular atrophy,212,epoxides,[CHEBI:32955]
Histone deacetylase inhibition leading to testicular atrophy,212,short-chain fatty acids,[mesh:D005232]
Histone deacetylase inhibition leading to testicular atrophy,212,hydroxamic acids,[mesh:D006877]
Histone deacetylase inhibition leading to testicular atrophy,212,benzamides,[mesh:D001549]
Histone deacetylase inhibition leading to testicular atrophy,212,MAA,[CHEBI:35738]
Histone deacetylase inhibition leading to testicular atrophy,212,2-Methoxyacetic acid,[mesh:C013598]
Inhibition of pyruvate dehydrogenase kinase leading to hepatocellular adenomas and carcinomas (in mouse and rat),108,pyruvate,[mesh:D019289]
Inhibition of fatty acid beta oxidation leading to nonalcoholic steatohepatitis (NASH),213,sugars,[mesh:D000073893]
Inhibition of fatty acid beta oxidation leading to nonalcoholic steatohepatitis (NASH),213,fatty acid,[mesh:D005227]
Inhibition of fatty acid beta oxidation leading to nonalcoholic steatohepatitis (NASH),213,glucose,[CHEBI:42758]
Inhibition of fatty acid beta oxidation leading to nonalcoholic steatohepatitis (NASH),213,triglycerides,[mesh:D014280]
Alkylation of DNA in male pre-meiotic germ cells leading to heritable mutations,15,nucleotides,[mesh:D009711]
Alkylation of DNA in male pre-meiotic germ cells leading to heritable mutations,15,methyl,[CHEBI:32875]
Network of SSRIs (selective serotonin reuptake inhibitors),214,serotonin,[CHEBI:350546]
Inhibition of iodide pump activity leading to follicular cell adenomas and carcinomas (in rat and mouse),110,iodide,[mesh:D007454]
Binding of electrophilic chemicals to SH(thiol)-group of proteins and /or to seleno-proteins involved in protection against oxidative stress during brain development leads to impairment of learning and memory,17,sulfhydryl,[CHEBI:29917]
Binding of electrophilic chemicals to SH(thiol)-group of proteins and /or to seleno-proteins involved in protection against oxidative stress during brain development leads to impairment of learning and memory,17,glutamate,[mesh:D018698]
Binding of electrophilic chemicals to SH(thiol)-group of proteins and /or to seleno-proteins involved in protection against oxidative stress during brain development leads to impairment of learning and memory,17,SH,[CHEBI:73651]
Binding of electrophilic chemicals to SH(thiol)-group of proteins and /or to seleno-proteins involved in protection against oxidative stress during brain development leads to impairment of learning and memory,17,thiol,[mesh:D013438]
Binding of electrophilic chemicals to SH(thiol)-group of proteins and /or to seleno-proteins involved in protection against oxidative stress during brain development leads to impairment of learning and memory,17,seleno,[CHEBI:16503]
Binding of electrophilic chemicals to SH(thiol)-group of proteins and /or to seleno-proteins involved in protection against oxidative stress during brain development leads to impairment of learning and memory,17,Oxygen,[mesh:D010100]
Binding of electrophilic chemicals to SH(thiol)-group of proteins and /or to seleno-proteins involved in protection against oxidative stress during brain development leads to impairment of learning and memory,17,glutathione,[CHEBI:57925]
Binding of electrophilic chemicals to SH(thiol)-group of proteins and /or to seleno-proteins involved in protection against oxidative stress during brain development leads to impairment of learning and memory,17,mercury,[mesh:D008628]
Binding of electrophilic chemicals to SH(thiol)-group of proteins and /or to seleno-proteins involved in protection against oxidative stress during brain development leads to impairment of learning and memory,17,GSH,[mesh:D005978]
Decrease in androgen receptor activity leading to Leydig cell tumors (in rat),111,Androgen,[mesh:D000728]
PPARα activation in utero leading to impaired fertility in males,18,steroid,[mesh:D013256]
PPARα activation in utero leading to impaired fertility in males,18,cholesterol,[mesh:D002784]
Estrogen Receptor Activation and Female Precocious Puberty,146,Estrogen,[mesh:D004967]
Androgen receptor antagonism leading to adverse effects in the male foetus (mammals),19,phthalimide,[mesh:C037431]
Androgen receptor antagonism leading to adverse effects in the male foetus (mammals),19,anilides,[mesh:D000813]
Androgen receptor antagonism leading to adverse effects in the male foetus (mammals),19,quinoline,[mesh:C037219]
Androgen receptor antagonism leading to adverse effects in the male foetus (mammals),19,linuron,[mesh:D008044]
Androgen receptor antagonism leading to adverse effects in the male foetus (mammals),19,hydantoin,[CHEBI:27612]
Androgen receptor antagonism leading to adverse effects in the male foetus (mammals),19,nilutamide,[mesh:C021277]
Androgen receptor antagonism leading to adverse effects in the male foetus (mammals),19,vinclozin,[mesh:C025643]
Androgen receptor antagonism leading to adverse effects in the male foetus (mammals),19,bicalutamide,[mesh:C053541]
Androgen receptor antagonism leading to adverse effects in the male foetus (mammals),19,Androgen,[mesh:D000728]
Androgen receptor antagonism leading to adverse effects in the male foetus (mammals),19,5-alpha-dihydrotestosterone,[mesh:D013196]
Androgen receptor antagonism leading to adverse effects in the male foetus (mammals),19,aryl amide,[CHEBI:62733]
Androgen receptor antagonism leading to adverse effects in the male foetus (mammals),19,testosterone,[mesh:D013739]
Androgen receptor antagonism leading to adverse effects in the male foetus (mammals),19,flutamide,[mesh:D005485]
Androgen receptor antagonism leading to adverse effects in the male foetus (mammals),19,cyproterone acetate,[mesh:D017373]
Androgen receptor antagonism leading to adverse effects in the male foetus (mammals),19,steroid,[mesh:D013256]
Androgen receptor antagonism leading to adverse effects in the male foetus (mammals),19,metribolone,[mesh:D015741]
Androgen receptor antagonism leading to adverse effects in the male foetus (mammals),19,mibolerone,[mesh:C100075]
Inhibition of CYP7B activity leads to decreased reproductive success via decreased locomotor activity,218,7-hydroxypregnenolone,[mesh:C495856]
Inhibition of CYP7B activity leads to decreased reproductive success via decreased locomotor activity,218,azole,[CHEBI:19203]
Inhibition of CYP7B activity leads to decreased reproductive success via decreased locomotor activity,218,heme,[mesh:D006418]
Inhibition of CYP7B activity leads to decreased reproductive success via decreased locomotor activity,218,dopamine,[mesh:D004298]
Inhibition of CYP7B activity leads to decreased reproductive success via decreased locomotor activity,218,pregnenolone,[mesh:D011284]
Androgen receptor agonism leading to reproductive dysfunction (in repeat-spawning fish),23,Androgen,[mesh:D000728]
Inhibition of CYP7B activity leads to decreased reproductive success via decreased sexual behavior,219,7-hydroxypregnenolone,[mesh:C495856]
Inhibition of CYP7B activity leads to decreased reproductive success via decreased sexual behavior,219,azole,[CHEBI:19203]
Inhibition of CYP7B activity leads to decreased reproductive success via decreased sexual behavior,219,heme,[mesh:D006418]
Inhibition of CYP7B activity leads to decreased reproductive success via decreased sexual behavior,219,dopamine,[mesh:D004298]
Inhibition of CYP7B activity leads to decreased reproductive success via decreased sexual behavior,219,pregnenolone,[mesh:D011284]
Peptide Oxidation Leading to Hypertension,149,amino acids,[mesh:D000596]
Peptide Oxidation Leading to Hypertension,149,GTPCH,[mesh:C046512]
Peptide Oxidation Leading to Hypertension,149,guanosine,[mesh:D006151]
Peptide Oxidation Leading to Hypertension,149,GSSG,[mesh:D019803]
Peptide Oxidation Leading to Hypertension,149,superoxide,[mesh:D013481]
Peptide Oxidation Leading to Hypertension,149,tetrahydrobiopterin,[mesh:C003402]
Peptide Oxidation Leading to Hypertension,149,BH4,[CHEBI:30158]
Peptide Oxidation Leading to Hypertension,149,glutathione,[CHEBI:57925]
Peptide Oxidation Leading to Hypertension,149,nicotine,[mesh:D009538]
Peptide Oxidation Leading to Hypertension,149,nitric oxide,[mesh:D009569]
Peptide Oxidation Leading to Hypertension,149,GSH,[mesh:D005978]
Calcium-mediated neuronal ROS production and energy imbalance,26,Calcium,[mesh:D002118]
Androgen receptor activation leading to hepatocellular adenomas and carcinomas (in mouse and rat),117,Androgen,[mesh:D000728]
Cholestatic Liver Injury induced by Inhibition of the Bile Salt Export Pump (ABCB11),27,Bile Salt,[mesh:D001647]
Serotonin transporter activation to seizure,223,serotonin,[CHEBI:350546]
Serotonin transporter activation to depression,224,serotonin,[CHEBI:350546]
Estrogen receptor agonism leading to reproductive dysfunction,29,Estrogen,[mesh:D004967]
Serotonin transporter activation to agitation,225,serotonin,[CHEBI:350546]
Estrogen receptor antagonism leading to reproductive dysfunction,30,Estrogen,[mesh:D004967]
SSRI (Selective serotonin reuptake inhibitor) to hypertension,226,serotonin,[CHEBI:350546]
Oxidation of iron in hemoglobin leading to hematotoxicity,31,NADPH,[CHEBI:57783]
Oxidation of iron in hemoglobin leading to hematotoxicity,31,iron,[mesh:D007501]
Oxidation of iron in hemoglobin leading to hematotoxicity,31,aniline,[mesh:C023650]
Oxidation of iron in hemoglobin leading to hematotoxicity,31,Iron(II),[CHEBI:29033]
Oxidation of iron in hemoglobin leading to hematotoxicity,31,heme,[mesh:D006418]
Oxidation of iron in hemoglobin leading to hematotoxicity,31,"2,4-",[CHEBI:30772]
Oxidation of iron in hemoglobin leading to hematotoxicity,31,dinitrotoluene,[CHEBI:23822]
Oxidation of iron in hemoglobin leading to hematotoxicity,31,"2,4-DNT",[CHEBI:920]
Oxidation of iron in hemoglobin leading to hematotoxicity,31,N-hydroxyl anilines,[mesh:D000627]
Oxidation of iron in hemoglobin leading to hematotoxicity,31,Iron(III),[CHEBI:29034]
Oxidation of iron in hemoglobin leading to hematotoxicity,31,"2,4,6-trinitrotoluene",[mesh:D014303]
Oxidation of iron in hemoglobin leading to hematotoxicity,31,glutathione,[CHEBI:57925]
Oxidation of iron in hemoglobin leading to hematotoxicity,31,Glucose-6-phosphate,[mesh:D019298]
Prolyl hydroxylase inhibition leading to reproductive dysfunction via increased HIF1 heterodimer formation,122,Prolyl,[CHEBI:26274]
Interference with thyroid serum binding protein transthyretin and subsequent adverse human neurodevelopmental toxicity,152,thyroxine (T4,[mesh:D013974]
LXR activation leading to hepatic steatosis,34,fatty acid,[mesh:D005227]
LXR activation leading to hepatic steatosis,34,triglycerides,[mesh:D014280]
LXR activation leading to hepatic steatosis,34,carbohydrate,[mesh:D002241]
LXR activation leading to hepatic steatosis,34,sterol,[mesh:D013261]
LXR activation leading to hepatic steatosis,34,stearoyl-CoA,[mesh:C017725]
Glutamate-gated chloride channel activation leading to acute mortality,113,lactones,[mesh:D007783]
Glutamate-gated chloride channel activation leading to acute mortality,113,glutamate,[mesh:D018698]
Glutamate-gated chloride channel activation leading to acute mortality,113,abermectin,[CHEBI:73285]
Glutamate-gated chloride channel activation leading to acute mortality,113,ivermectin,[mesh:D007559]
Glutamate-gated chloride channel activation leading to acute mortality,113,lactone,[mesh:D014307]
Glutamate-gated chloride channel activation leading to acute mortality,113,acetylcholine,[mesh:D000109]
Glutamate-gated chloride channel activation leading to acute mortality,113,Cys,[CHEBI:32447]
Glutamate-gated chloride channel activation leading to acute mortality,113,dopamine,[mesh:D004298]
Glutamate-gated chloride channel activation leading to acute mortality,113,GABA,[mesh:D005680]
Glutamate-gated chloride channel activation leading to acute mortality,113,chloride,[CHEBI:15767]
Glutamate-gated chloride channel activation leading to acute mortality,113,serotonin,[CHEBI:350546]
Glutamate-gated chloride channel activation leading to acute mortality,113,GluCl,[mesh:D005913]
Glutamate-gated chloride channel activation leading to acute mortality,113,Abamectin,[mesh:C048324]
Glutamate-gated chloride channel activation leading to acute mortality,113,Histamine,[CHEBI:58432]
HMG-CoA reductase inhibition leading to decreased fertility,124,statins,[mesh:C086276]
HMG-CoA reductase inhibition leading to decreased fertility,124,HMG-CoA,[mesh:C008047]
HMG-CoA reductase inhibition leading to decreased fertility,124,cholesteron,[CHEBI:63906]
HMG-CoA reductase inhibition leading to decreased fertility,124,testosterone,[mesh:D013739]
Thyroperoxidase inhibition leading to increased mortality via reduced anterior swim bladder inflation,159,iodide,[mesh:D007454]
Thyroperoxidase inhibition leading to increased mortality via reduced anterior swim bladder inflation,159,thyroxine (T4,[mesh:D013974]
Thyroperoxidase inhibition leading to increased mortality via reduced anterior swim bladder inflation,159,triiodothyronine,[mesh:D014284]
Thyroperoxidase inhibition leading to increased mortality via reduced anterior swim bladder inflation,159,hydrogen peroxide,[mesh:D006861]
Ionotropic gamma-aminobutyric acid receptor activation mediated neurotransmission inhibition leading to mortality,160,GABA,[mesh:D005680]
Peroxisomal Fatty Acid Beta-Oxidation Inhibition Leading to Steatosis,36,fatty acid,[mesh:D005227]
S-adenosylmethionine depletion leading to population decline (2),343,S-adenosylmethionine,[CHEBI:67040]
Glutamate-gated chloride channel activation leading to neurotransmission inhibition associated mortality,161,glutamate,[mesh:D018698]
Glutamate-gated chloride channel activation leading to neurotransmission inhibition associated mortality,161,chloride,[CHEBI:15767]
PPARα activation leading to hepatocellular adenomas and carcinomas in rodents,37,fatty acid,[mesh:D005227]
PPARα activation leading to hepatocellular adenomas and carcinomas in rodents,37,DEHP,[mesh:D004051]
PPARα activation leading to hepatocellular adenomas and carcinomas in rodents,37,gemfibrozil,[mesh:D015248]
PPARα activation leading to hepatocellular adenomas and carcinomas in rodents,37,9-cis-retinoic acid,[mesh:D000077556]
PPARα activation leading to hepatocellular adenomas and carcinomas in rodents,37,phthalate ester,[CHEBI:35484]
Mu Opioid Receptor Agonism leading to Analgesia via K Channel Opening,233,K+,[CHEBI:29103]
Mu Opioid Receptor Agonism leading to Analgesia via Ca Channel Inhibition,234,Ca,[CHEBI:39099]
Mu Opioid Receptor Agonism leading to Analgesia via Ca Channel Inhibition,234,Ca2+,[CHEBI:29108]
Sodium Iodide Symporter (NIS) Inhibition and Subsequent Adverse Neurodevelopmental Outcomes in Mammals,134,iodine,[mesh:D007455]
Sodium Iodide Symporter (NIS) Inhibition and Subsequent Adverse Neurodevelopmental Outcomes in Mammals,134,Sodium Iodide,[mesh:D012974]
Sodium Iodide Symporter (NIS) Inhibition and Subsequent Adverse Neurodevelopmental Outcomes in Mammals,134,sodium iodine,[CHEBI:33167]
Covalent Protein binding leading to Skin Sensitisation,40,lysine,[mesh:D008239]
Covalent Protein binding leading to Skin Sensitisation,40,cysteine,[mesh:D003545]
Serotonin 1A Receptor Agonism leading to Anti-depressant Activity via K Channel Opening,235,K+,[CHEBI:29103]
Serotonin 1A Receptor Agonism leading to Anti-depressant Activity via K Channel Opening,235,serotonin,[CHEBI:350546]
Antiestrogen activity leading to ovarian adenomas and granular cell tumors in the mouse,165,Antiestrogens,[mesh:D020847]
Sustained AhR Activation leading to Rodent Liver Tumours,41,dioxin,[mesh:D004147]
Sustained AhR Activation leading to Rodent Liver Tumours,41,indole-3-carbinol,[mesh:C016517]
Sustained AhR Activation leading to Rodent Liver Tumours,41,DLCs,[CHEBI:73430]
Sustained AhR Activation leading to Rodent Liver Tumours,41,aryl hydrocarbon,[mesh:D006841]
Inhibition of Thyroperoxidase and Subsequent Adverse Neurodevelopmental Outcomes in Mammals,42,propylthiouracil,[mesh:D011441]
Early-life estrogen receptor activity leading to endometrial carcinoma in the mouse.,167,Estrogen,[mesh:D004967]
Inhibition of Calcineurin Activity Leading to Impaired T-Cell Dependent Antibody Response,154,FK506,[mesh:D016559]
Inhibition of Calcineurin Activity Leading to Impaired T-Cell Dependent Antibody Response,154,CsA,[CHEBI:55379]
"Binding of agonists to ionotropic glutamate receptors in adult brain causes excitotoxicity that mediates neuronal cell death, contributing to learning and memory impairment.",48,domoic acid,[mesh:C012301]
"Binding of agonists to ionotropic glutamate receptors in adult brain causes excitotoxicity that mediates neuronal cell death, contributing to learning and memory impairment.",48,glufosinate,[mesh:C003121]
"Binding of agonists to ionotropic glutamate receptors in adult brain causes excitotoxicity that mediates neuronal cell death, contributing to learning and memory impairment.",48,methylphosphine,[CHEBI:35887]
"Binding of agonists to ionotropic glutamate receptors in adult brain causes excitotoxicity that mediates neuronal cell death, contributing to learning and memory impairment.",48,aspartate,[mesh:D001224]
"Binding of agonists to ionotropic glutamate receptors in adult brain causes excitotoxicity that mediates neuronal cell death, contributing to learning and memory impairment.",48,glutamate,[mesh:D018698]
"Binding of agonists to ionotropic glutamate receptors in adult brain causes excitotoxicity that mediates neuronal cell death, contributing to learning and memory impairment.",48,amino acids,[mesh:D000596]
"Binding of agonists to ionotropic glutamate receptors in adult brain causes excitotoxicity that mediates neuronal cell death, contributing to learning and memory impairment.",48,polyamines,[mesh:D011073]
"Binding of agonists to ionotropic glutamate receptors in adult brain causes excitotoxicity that mediates neuronal cell death, contributing to learning and memory impairment.",48,spermidine,[mesh:D013095]
"Binding of agonists to ionotropic glutamate receptors in adult brain causes excitotoxicity that mediates neuronal cell death, contributing to learning and memory impairment.",48,homocysteine,[mesh:D006710]
"Binding of agonists to ionotropic glutamate receptors in adult brain causes excitotoxicity that mediates neuronal cell death, contributing to learning and memory impairment.",48,DomA,[CHEBI:27637]
"Binding of agonists to ionotropic glutamate receptors in adult brain causes excitotoxicity that mediates neuronal cell death, contributing to learning and memory impairment.",48,GLF,[mesh:D020904]
"Binding of agonists to ionotropic glutamate receptors in adult brain causes excitotoxicity that mediates neuronal cell death, contributing to learning and memory impairment.",48,ATP,[CHEBI:30616]
"Binding of agonists to ionotropic glutamate receptors in adult brain causes excitotoxicity that mediates neuronal cell death, contributing to learning and memory impairment.",48,Ca2+,[CHEBI:29108]
"Binding of agonists to ionotropic glutamate receptors in adult brain causes excitotoxicity that mediates neuronal cell death, contributing to learning and memory impairment.",48,kainate,[mesh:D007608]
"Binding of agonists to ionotropic glutamate receptors in adult brain causes excitotoxicity that mediates neuronal cell death, contributing to learning and memory impairment.",48,ibotenic acid,[mesh:D007051]
"Binding of agonists to ionotropic glutamate receptors in adult brain causes excitotoxicity that mediates neuronal cell death, contributing to learning and memory impairment.",48,alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropiona,[mesh:D018350]
"Binding of agonists to ionotropic glutamate receptors in adult brain causes excitotoxicity that mediates neuronal cell death, contributing to learning and memory impairment.",48,N-methyl-D-aspartate,[mesh:D016202]
Inhibition of lysyl oxidase leading to enhanced chronic fish toxicity,242,dithiocarbamates,[CHEBI:38129]
Inhibition of lysyl oxidase leading to enhanced chronic fish toxicity,242,thiram,[mesh:D013893]
Inhibition of lysyl oxidase leading to enhanced chronic fish toxicity,242,ziram,[mesh:D015039]
Inhibition of lysyl oxidase leading to enhanced chronic fish toxicity,242,NaDTMC,[mesh:C071798]
Inhibition of lysyl oxidase leading to enhanced chronic fish toxicity,242,maneb,[mesh:D008344]
Inhibition of lysyl oxidase leading to enhanced chronic fish toxicity,242,lysyl,[CHEBI:32568]
Reduction in photophosphorylation leading to growth inhibition in aquatic plants,245,"3,5-dichlorophenol",[mesh:C116190]
Estrogen receptor agonism leads to reduced fecundity via increased vitellogenin in the liver,537,Estrogen,[mesh:D004967]
Estrogen receptor agonism leads to reduced fecundity via increased vitellogenin in the liver,537,vitellogenin,[mesh:C073189]
Thyroperoxidase inhibition leading to altered amphibian metamorphosis,175,thyroxine (T4,[mesh:D013974]
Thyroperoxidase inhibition leading to altered amphibian metamorphosis,175,iodothyronine,[CHEBI:24864]
Thyroperoxidase inhibition leading to altered amphibian metamorphosis,175,tyrosyl,[CHEBI:32789]
Thyroperoxidase inhibition leading to altered amphibian metamorphosis,175,benzophenone-2,[mesh:C035476]
Thyroperoxidase inhibition leading to altered amphibian metamorphosis,175,triiodothyronine,[mesh:D014284]
Thyroperoxidase inhibition leading to altered amphibian metamorphosis,175,methimazole,[mesh:D008713]
Thyroperoxidase inhibition leading to altered amphibian metamorphosis,175,6-propylthiouracil,[CHEBI:8502]
Thyroperoxidase inhibition leading to altered amphibian metamorphosis,175,2-mercaptobenzothiazole,[mesh:C005563]
Inhibition of mitochondrial DNA polymerase gamma leading to kidney toxicity,256,nucleotides,[mesh:D009711]
Inhibition of mitochondrial DNA polymerase gamma leading to kidney toxicity,256,Nucleoside,[mesh:D009705]
Inhibition of mitochondrial DNA polymerase gamma leading to kidney toxicity,256,nucleos(t)ide,[CHEBI:33252]
Sodium Iodide Symporter (NIS) Inhibition leading to altered amphibian metamorphosis,176,tyrosine,[mesh:D014443]
Sodium Iodide Symporter (NIS) Inhibition leading to altered amphibian metamorphosis,176,tyrosines,[CHEBI:18186]
Sodium Iodide Symporter (NIS) Inhibition leading to altered amphibian metamorphosis,176,thyroxine (T4,[mesh:D013974]
Sodium Iodide Symporter (NIS) Inhibition leading to altered amphibian metamorphosis,176,perchlorate,[mesh:C494474]
Sodium Iodide Symporter (NIS) Inhibition leading to altered amphibian metamorphosis,176,triiodothyronine,[mesh:D014284]
Sodium Iodide Symporter (NIS) Inhibition leading to altered amphibian metamorphosis,176,iodine,[mesh:D007455]
Sodium Iodide Symporter (NIS) Inhibition leading to altered amphibian metamorphosis,176,Sodium Iodide,[mesh:D012974]
Serotonin 1A Receptor Agonism leading to Anti-depressant Activity via Ca Channel Inhibition,236,Ca,[CHEBI:39099]
Serotonin 1A Receptor Agonism leading to Anti-depressant Activity via Ca Channel Inhibition,236,Ca2+,[CHEBI:29108]
Serotonin 1A Receptor Agonism leading to Anti-depressant Activity via Ca Channel Inhibition,236,serotonin,[CHEBI:350546]
Inhibition of Na+/I- symporter (NIS) leads to learning and memory impairment,54,I,[CHEBI:30009]
Inhibition of Na+/I- symporter (NIS) leads to learning and memory impairment,54,thyroid hormones,[mesh:D013963]
Inhibition of Na+/I- symporter (NIS) leads to learning and memory impairment,54,iodide,[mesh:D007454]
Inhibition of Na+/I- symporter (NIS) leads to learning and memory impairment,54,Na+,[CHEBI:29101]
Nicotinic acetylcholine receptor activation contributes to mitochondrial dysfunction and leads to colony loss/failure,178,acetylcholine,[mesh:D000109]
Inhibition of AChE and activation of CYP2E1 leading to sensory axonal peripheral neuropathy and mortality,450,methyl parathion,[mesh:D008743]
Inhibition of AChE and activation of CYP2E1 leading to sensory axonal peripheral neuropathy and mortality,450,Oxygen,[mesh:D010100]
Inhibition of AChE and activation of CYP2E1 leading to sensory axonal peripheral neuropathy and mortality,450,tabun,[mesh:C009374]
Inhibition of AChE and activation of CYP2E1 leading to sensory axonal peripheral neuropathy and mortality,450,ethyl parathion,[mesh:D010278]
Inhibition of AChE and activation of CYP2E1 leading to sensory axonal peripheral neuropathy and mortality,450,serine,[mesh:D012694]
Inhibition of AChE and activation of CYP2E1 leading to sensory axonal peripheral neuropathy and mortality,450,phosphate,[mesh:D010710]
Inhibition of AChE and activation of CYP2E1 leading to sensory axonal peripheral neuropathy and mortality,450,sarin,[mesh:D012524]
Inhibition of AChE and activation of CYP2E1 leading to sensory axonal peripheral neuropathy and mortality,450,paraoxon,[mesh:D010261]
Inhibition of AChE and activation of CYP2E1 leading to sensory axonal peripheral neuropathy and mortality,450,organophosphate,[mesh:D010755]
Ceramide synthase inhibition leading to neural tube defects,449,FB1,[CHEBI:38221]
Ceramide synthase inhibition leading to neural tube defects,449,folate,[CHEBI:62501]
Ceramide synthase inhibition leading to neural tube defects,449,fumonisins,[mesh:D037341]
Ceramide synthase inhibition leading to neural tube defects,449,Ceramide,[CHEBI:52639]
Ceramide synthase inhibition leading to neural tube defects,449,fumonisin FB1,[mesh:C056933]
Mitochondrial ATP synthase antagonism leading to growth inhibition (2),291,ATP,[CHEBI:30616]
"Kidney failure induced by inhibition of mitochondrial electron transfer chain through apoptosis, inflammation and oxidative stress pathways",447,Sodium,[mesh:D012964]
"Kidney failure induced by inhibition of mitochondrial electron transfer chain through apoptosis, inflammation and oxidative stress pathways",447,phosphate,[mesh:D010710]
Succinate dehydrogenase inhibition leading to increased insulin resistance through reduction in circulating thyroxine,457,phthalate,[CHEBI:17563]
Succinate dehydrogenase inhibition leading to increased insulin resistance through reduction in circulating thyroxine,457,Oxygen,[mesh:D010100]
Succinate dehydrogenase inhibition leading to increased insulin resistance through reduction in circulating thyroxine,457,glucose,[CHEBI:42758]
Succinate dehydrogenase inhibition leading to increased insulin resistance through reduction in circulating thyroxine,457,DEHP,[mesh:D004051]
Succinate dehydrogenase inhibition leading to increased insulin resistance through reduction in circulating thyroxine,457,phthalate ester,[CHEBI:35484]
Succinate dehydrogenase inhibition leading to increased insulin resistance through reduction in circulating thyroxine,457,Succinate,[mesh:D019802]
Succinate dehydrogenase inhibition leading to increased insulin resistance through reduction in circulating thyroxine,457,thydroid,[CHEBI:17821]
Reactive oxygen species and subsequent oxidative stress lead to increased incidence of digestive morbidity and mortality in the general population,453,Oxygen,[mesh:D010100]
Activation of reactive oxygen species leading the atherosclerosis,462,Oxygen,[mesh:D010100]
AhR activation in the liver leading to Subsequent Adverse Neurodevelopmental Outcomes in Mammals,458,8 tetrachlorodibenzo-p-dioxin,[CHEBI:28119]
AhR activation in the liver leading to Subsequent Adverse Neurodevelopmental Outcomes in Mammals,458,PCB-126,[mesh:C023035]
AhR activation in the liver leading to Subsequent Adverse Neurodevelopmental Outcomes in Mammals,458,polychlorinated biphenyls,[CHEBI:53156]
AhR activation in the liver leading to Subsequent Adverse Neurodevelopmental Outcomes in Mammals,458,ITE,[mesh:C005801]
AhR activation in the liver leading to Subsequent Adverse Neurodevelopmental Outcomes in Mammals,458,TCDD,[mesh:D013749]
AhR activation in the liver leading to Subsequent Adverse Neurodevelopmental Outcomes in Mammals,458,dioxin,[mesh:D004147]
AhR activation in the liver leading to Subsequent Adverse Neurodevelopmental Outcomes in Mammals,458,PCB-169,[mesh:C027309]
AhR activation in the thyroid leading to Subsequent Adverse Neurodevelopmental Outcomes in Mammals,459,8 tetrachlorodibenzo-p-dioxin,[CHEBI:28119]
AhR activation in the thyroid leading to Subsequent Adverse Neurodevelopmental Outcomes in Mammals,459,PCB-126,[mesh:C023035]
AhR activation in the thyroid leading to Subsequent Adverse Neurodevelopmental Outcomes in Mammals,459,Oxygen,[mesh:D010100]
AhR activation in the thyroid leading to Subsequent Adverse Neurodevelopmental Outcomes in Mammals,459,polychlorinated biphenyls,[CHEBI:53156]
AhR activation in the thyroid leading to Subsequent Adverse Neurodevelopmental Outcomes in Mammals,459,TCDD,[mesh:D013749]
AhR activation in the thyroid leading to Subsequent Adverse Neurodevelopmental Outcomes in Mammals,459,dioxin,[mesh:D004147]
AhR activation in the thyroid leading to Subsequent Adverse Neurodevelopmental Outcomes in Mammals,459,PCB-169,[mesh:C027309]
The AOP framwork on silica nanopariticles induced hepatoxicity,463,silica,[mesh:D012822]
Alcohol dehydrogenase leading to reproductive dysfunction,465,Estrogen,[mesh:D004967]
Alcohol dehydrogenase leading to reproductive dysfunction,465,alcohol,[CHEBI:16236]
Alcohol dehydrogenase leading to reproductive dysfunction,465,DEHP,[mesh:D004051]
Calcium overload in dopaminergic neurons of the substantia nigra leading to parkinsonian motor deficits,464,Calcium,[mesh:D002118]
Energy deposition from internalized Ra-226 decay lower oxygen binding capacity of hemocyanin,473,Oxygen,[mesh:D010100]
Energy deposition from internalized Ra-226 decay lower oxygen binding capacity of hemocyanin,473,Ra226,[mesh:C035279]
Energy deposition from internalized Ra-226 decay lower oxygen binding capacity of hemocyanin,473,Ra-226,[mesh:C000615152]
Succinate dehydrogenase inactivation leads to cancer by promoting EMT,474,Oxygen,[mesh:D010100]
Succinate dehydrogenase inactivation leads to cancer by promoting EMT,474,fumarate,[CHEBI:29806]
Succinate dehydrogenase inactivation leads to cancer by promoting EMT,474,Succinate,[mesh:D019802]
Succinate dehydrogenase inactivation leads to cancer by promoting EMT,474,ubiquinone,[mesh:D014451]
Succinate dehydrogenase inactivation leads to cancer by promoting EMT,474,Calcium,[mesh:D002118]
Reactive oxygen speicies overproduction leading to increased digestive morbidity and mortality in generation population,469,Oxygen,[mesh:D010100]
Doda decarboxylase leading to mortality,466,dopamine,[mesh:D004298]
Doda decarboxylase leading to mortality,466,"3,4-dihydroxyphenylalanine",[CHEBI:49168]
Deposition of energy leading to occurrence of bone loss,482,amino acids,[mesh:D000596]
Adverse Outcome Pathways diagram related to PBDEs associated male reproductive toxicity,476,polybrominated diphenyl ethers,[mesh:D055768]
Androgen receptor (AR) antagonism leading to hypospadias in male (mammalian) offspring,477,Androgen,[mesh:D000728]
Mitochondrial complexes inhibition leading to heart failure via decreased ATP production,480,ATP,[CHEBI:30616]
Inhibition of Cystathionine Beta synthase leading to impaired the early development of anterior-posterior axis,301,glutamate,[mesh:D018698]
Inhibition of Cystathionine Beta synthase leading to impaired the early development of anterior-posterior axis,301,amino acids,[mesh:D000596]
Inhibition of Cystathionine Beta synthase leading to impaired the early development of anterior-posterior axis,301,homocysteine,[mesh:D006710]
Inhibition of Cystathionine Beta synthase leading to impaired the early development of anterior-posterior axis,301,dopamine,[mesh:D004298]
Inhibition of Cystathionine Beta synthase leading to impaired the early development of anterior-posterior axis,301,Aminooxyacetic acid,[mesh:D000625]
Inhibition of Cystathionine Beta synthase leading to impaired the early development of anterior-posterior axis,301,betaine,[mesh:D001622]
Inhibition of Cystathionine Beta synthase leading to impaired the early development of anterior-posterior axis,301,Hcy,[CHEBI:17588]
Inhibition of Cystathionine Beta synthase leading to impaired the early development of anterior-posterior axis,301,cystathione,[CHEBI:17755]
Inhibition of Cystathionine Beta synthase leading to impaired the early development of anterior-posterior axis,301,methionine,[CHEBI:16643]
Inhibition of Cystathionine Beta synthase leading to impaired the early development of anterior-posterior axis,301,superoxide,[mesh:D013481]
Inhibition of Cystathionine Beta synthase leading to impaired the early development of anterior-posterior axis,301,Ca2+,[CHEBI:29108]
Inhibition of Cystathionine Beta synthase leading to impaired the early development of anterior-posterior axis,301,hydrogen sulfide,[mesh:D006862]
Inhibition of Cystathionine Beta synthase leading to impaired the early development of anterior-posterior axis,301,Cystathionine,[mesh:D003540]
Inhibition of Cystathionine Beta synthase leading to impaired the early development of anterior-posterior axis,301,cysteine,[mesh:D003545]
Inhibition of Cystathionine Beta synthase leading to impaired the early development of anterior-posterior axis,301,alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropiona,[mesh:D018350]
Inhibition of Cystathionine Beta synthase leading to impaired the early development of anterior-posterior axis,301,H2S,[CHEBI:16136]
Inhibition of Cystathionine Beta synthase leading to impaired the early development of anterior-posterior axis,301,N-methyl-D-aspartate,[mesh:D016202]
AOPs of amorphous silica nanoparticles: ROS-mediated oxidative stress increased respiratory dysfunction and diseases.,481,silica,[mesh:D012822]
Increased LCN2/iron complex leading to neurological disorders,498,iron,[mesh:D007501]
Increased LCN2/iron complex leading to neurological disorders,498,Oxygen,[mesh:D010100]
Activation of MEK-ERK1/2 leads to deficits in learning and cognition via disrupted neurotransmitter release,499,Pb,[CHEBI:53319]
Activation of MEK-ERK1/2 leads to deficits in learning and cognition via disrupted neurotransmitter release,499,Mn,[CHEBI:18291]
Activation of MEK-ERK1/2 leads to deficits in learning and cognition via disrupted neurotransmitter release,499,arsenic,[mesh:D001151]
Activation of MEK-ERK1/2 leads to deficits in learning and cognition via disrupted neurotransmitter release,499,As,[CHEBI:47217]
Activation of MEK-ERK1/2 leads to deficits in learning and cognition via disrupted neurotransmitter release,499,Ca2+,[CHEBI:29108]
Activation of MEK-ERK1/2 leads to deficits in learning and cognition via disrupted neurotransmitter release,499,Cd,[CHEBI:22977]
Activation of MEK-ERK1/2 leads to deficits in learning and cognition via disrupted neurotransmitter release,499,cadmium,[mesh:D002104]
Activation of MEK-ERK1/2 leads to deficits in learning and cognition via disrupted neurotransmitter release,499,manganese,[mesh:D008345]
Activation of MEK-ERK1/2 leads to deficits in learning and cognition via disrupted neurotransmitter release,499,Calcium,[mesh:D002118]
Uncharacterized liver damage leading to hepatocellular carcinoma,1,"1,4-Dioxane",[mesh:C025223]
Uncharacterized liver damage leading to hepatocellular carcinoma,1,"1,1,1-trichloroethane",[mesh:C024566]
Androgen receptor activation leading to prostate cancer,495,Androgen,[mesh:D000728]
pentachlorophenol early events,5,RO8191,[mesh:C000655265]
pentachlorophenol early events,5,imiquimod,[mesh:D000077271]
pentachlorophenol early events,5,PCP,[CHEBI:41473]
pentachlorophenol early events,5,pentachlorophenol,[mesh:D010416]
Inhibition of the mitochondrial complex I of nigro-striatal neurons leads to parkinsonian motor deficits,3,dopamine,[mesh:D004298]
Inhibition of the mitochondrial complex I of nigro-striatal neurons leads to parkinsonian motor deficits,3,rotenone,[mesh:D012402]
Inhibition of the mitochondrial complex I of nigro-striatal neurons leads to parkinsonian motor deficits,3,"1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine",[mesh:D015632]
Androgen receptor agonism leading to reproduction dysfunction （in zebrafish）,496,17beta-trenbolone,[mesh:D014204]
Androgen receptor agonism leading to reproduction dysfunction （in zebrafish）,496,Androgen,[mesh:D000728]
Androgen receptor agonism leading to reproduction dysfunction （in zebrafish）,496,VTG,[mesh:D020888]
Androgen receptor agonism leading to reproduction dysfunction （in zebrafish）,496,11-KT,[mesh:C016531]
Ecdysone receptor agonism leading to incomplete ecdysis associated mortality,4,EDC,[CHEBI:27789]
Ecdysone receptor agonism leading to incomplete ecdysis associated mortality,4,Ecdysone,[mesh:D004440]
Ecdysone receptor agonism leading to incomplete ecdysis associated mortality,4,20E,[CHEBI:34306]
Ecdysone receptor agonism leading to incomplete ecdysis associated mortality,4,20-hydroxyecdysone,[mesh:D004441]
ERa inactivation alters mitochondrial functions and insulin signalling in skeletal muscle and leads to insulin resistance and metabolic syndrome,497,Estrogen,[mesh:D004967]
ERa inactivation alters mitochondrial functions and insulin signalling in skeletal muscle and leads to insulin resistance and metabolic syndrome,497,Oxygen,[mesh:D010100]
ERa inactivation alters mitochondrial functions and insulin signalling in skeletal muscle and leads to insulin resistance and metabolic syndrome,497,fatty acid,[mesh:D005227]
ERa inactivation alters mitochondrial functions and insulin signalling in skeletal muscle and leads to insulin resistance and metabolic syndrome,497,glucose,[CHEBI:42758]
AhR activation leading to liver fibrosis,494,alcohol,[CHEBI:16236]
AhR activation leading to liver fibrosis,494,dioxin,[mesh:D004147]
AhR activation leading to liver fibrosis,494,aryl hydrocarbon,[mesh:D006841]
AhR activation leading to liver fibrosis,494,tryptophan,[mesh:D014364]
Binding to the extracellular protein laminin leading to decreased cognitive function,486,DNT,[mesh:C023514]
Unknown MIE altering cholesterol metabolism leading to decreased cognition,487,cholesterol,[mesh:D002784]
Increased reactive oxygen species production leading to decreased cognitive function,488,Oxygen,[mesh:D010100]
Inhibition of voltage-gated sodium channels leading to decreased cognition,489,Sodium,[mesh:D012964]
Aryl hydrocarbon receptor activation leading to uroporphyria,131,Estrogen,[mesh:D004967]
Aryl hydrocarbon receptor activation leading to uroporphyria,131,uroporphyrin,[CHEBI:27259]
Aryl hydrocarbon receptor activation leading to uroporphyria,131,iron,[mesh:D007501]
Aryl hydrocarbon receptor activation leading to uroporphyria,131,Iron(II),[CHEBI:29033]
Aryl hydrocarbon receptor activation leading to uroporphyria,131,heme,[mesh:D006418]
Aryl hydrocarbon receptor activation leading to uroporphyria,131,carboxylated,[CHEBI:35757]
Aryl hydrocarbon receptor activation leading to uroporphyria,131,porphyrins,[mesh:D011166]
Aryl hydrocarbon receptor activation leading to uroporphyria,131,polychlorinated biphenyls,[CHEBI:53156]
Aryl hydrocarbon receptor activation leading to uroporphyria,131,tetrapyrrole,[mesh:D045725]
Aryl hydrocarbon receptor activation leading to uroporphyria,131,alcohol,[CHEBI:16236]
Aryl hydrocarbon receptor activation leading to uroporphyria,131,HCP,[CHEBI:30664]
Aryl hydrocarbon receptor activation leading to uroporphyria,131,porphyrin,[CHEBI:8337]
Aryl hydrocarbon receptor activation leading to uroporphyria,131,TCDD,[mesh:D013749]
Aryl hydrocarbon receptor activation leading to uroporphyria,131,Hexachlorobenzene,[mesh:D006581]
Aryl hydrocarbon receptor activation leading to uroporphyria,131,heptacarboxyl- and hexacarboxyl porphyrin,[mesh:C042771]
Aryl hydrocarbon receptor activation leading to uroporphyria,131,uroporphyrinogen,[mesh:D014577]
Aryl hydrocarbon receptor activation leading to uroporphyria,131,aryl hydrocarbon,[mesh:D006841]
Aryl hydrocarbon receptor activation leading to uroporphyria,131,coprouroporphyrinogen,[CHEBI:15438]
"Decrease, GLI1/2 target gene expression leads to orofacial clefting",491,cyclopamine,[mesh:C000541]
Glutathione conjugation leading to reproductive dysfunction via oxidative stress,492,hydroxynonenal,[CHEBI:16111]
Glutathione conjugation leading to reproductive dysfunction via oxidative stress,492,glutathione,[CHEBI:57925]
Glutathione conjugation leading to reproductive dysfunction via oxidative stress,492,malondialdehyde,[mesh:D008315]
Glutathione conjugation leading to reproductive dysfunction via oxidative stress,492,PESTICIDES,[mesh:D010575]
Glutathione conjugation leading to reproductive dysfunction via oxidative stress,492,GSH,[mesh:D005978]
Glutathione conjugation leading to reproductive dysfunction via oxidative stress,492,atrazine,[CHEBI:15930]
ERa inactivation alters AT expansion and functions and leads to insulin resistance and metabolically unhealthy obesity,493,Estrogen,[mesh:D004967]
Activation of MEK-ERK1/2 leads to deficits in learning and cognition via ROS and apoptosis,500,Pb,[CHEBI:53319]
Activation of MEK-ERK1/2 leads to deficits in learning and cognition via ROS and apoptosis,500,Mn,[CHEBI:18291]
Activation of MEK-ERK1/2 leads to deficits in learning and cognition via ROS and apoptosis,500,arsenic,[mesh:D001151]
Activation of MEK-ERK1/2 leads to deficits in learning and cognition via ROS and apoptosis,500,As,[CHEBI:47217]
Activation of MEK-ERK1/2 leads to deficits in learning and cognition via ROS and apoptosis,500,Ca2+,[CHEBI:29108]
Activation of MEK-ERK1/2 leads to deficits in learning and cognition via ROS and apoptosis,500,Cd,[CHEBI:22977]
Activation of MEK-ERK1/2 leads to deficits in learning and cognition via ROS and apoptosis,500,cadmium,[mesh:D002104]
Activation of MEK-ERK1/2 leads to deficits in learning and cognition via ROS and apoptosis,500,manganese,[mesh:D008345]
Activation of MEK-ERK1/2 leads to deficits in learning and cognition via ROS and apoptosis,500,Calcium,[mesh:D002118]
Inhibition of Fyna leading to increased mortality via decreased eye size (Microphthalmos),399,tyrosine,[mesh:D014443]
Inhibition of Fyna leading to increased mortality via decreased eye size (Microphthalmos),399,Saracatinib,[mesh:C515233]
Inhibition of Fyna leading to increased mortality via decreased eye size (Microphthalmos),399,Rosmarinic acid,[mesh:C041376]
Inhibition of Fyna leading to increased mortality via decreased eye size (Microphthalmos),399,Mastinib,[CHEBI:61399]
Inhibition of Fyna leading to increased mortality via decreased eye size (Microphthalmos),399,Staurosporine,[mesh:D019311]
Excessive iron accumulation leading to neurological disorders,501,iron,[mesh:D007501]
Acetylcholinesterase inhibition leading to acute mortality,16,acetylcholine,[mesh:D000109]
"Decrease, cholesterol synthesis leads to orofacial clefting",502,cholesterol,[mesh:D002784]
Deposition of ionizing energy leading to population decline via inhibition of photosynthesis,386,Oxygen,[mesh:D010100]
Deposition of ionizing energy leading to population decline via inhibition of photosynthesis,386,ATP,[CHEBI:30616]
Modulation of Adult Leydig Cell Function Subsequent to Proteomic Alterations in the Adult Leydig Cell,70,testosterone,[mesh:D013739]
Modulation of Adult Leydig Cell Function Subsequent to Decreased Cholesterol Synthesis or Transport in the Adult Leydig Cell,69,testosterone,[mesh:D013739]
Modulation of Adult Leydig Cell Function Subsequent to Decreased Cholesterol Synthesis or Transport in the Adult Leydig Cell,69,cholesterol,[mesh:D002784]
Modulation of Adult Leydig Cell Function Subsequent to Alterations in the Fetal Testis Protome,68,testosterone,[mesh:D013739]
Modulation of Adult Leydig Cell Function Subsequent to Estradiaol Activation in the Fetal Testis,67,testosterone,[mesh:D013739]
Modulation of Adult Leydig Cell Function Subsequent to Estradiaol Activation in the Fetal Testis,67,Estradiaol,[mesh:C000654743]
SULT1E1 inhibition leading to uterine adenocarcinoma via increased estrogen availability at target organ level,504,Estrogen,[mesh:D004967]
SULT1E1 inhibition leading to uterine adenocarcinoma via increased estrogen availability at target organ level,504,oestradiol,[mesh:D004958]
SULT1E1 inhibition leading to uterine adenocarcinoma via increased estrogen availability at target organ level,504,steroid,[mesh:D013256]
SULT1E1 inhibition leading to uterine adenocarcinoma via increased estrogen availability at target organ level,504,Sulfated steroids,[CHEBI:16158]
Nicotinic acetylcholine receptor activation contributes to abnormal role change within the worker bee caste leading to colony death failure 1,78,acetylcholine,[mesh:D000109]
Deposition of ionising energy leading to population decline via mitochondrial dysfunction,387,Oxygen,[mesh:D010100]
Deposition of ionising energy leading to population decline via mitochondrial dysfunction,387,ATP,[CHEBI:30616]
Reactive Oxygen Species (ROS) formation leads to cancer via inflammation pathway,505,Oxygen,[mesh:D010100]
Reactive Oxygen Species (ROS) formation leads to cancer via inflammation pathway,505,peroxyl,[CHEBI:25935]
Reactive Oxygen Species (ROS) formation leads to cancer via inflammation pathway,505,superoxide,[mesh:D013481]
Reactive Oxygen Species (ROS) formation leads to cancer via inflammation pathway,505,ozone,[mesh:D010126]
Reactive Oxygen Species (ROS) formation leads to cancer via inflammation pathway,505,hydroxyl,[mesh:D017665]
Modulation of Adult Leydig Cell Function Subsequent Glucocorticoid Activation in the Fetal Testis,66,testosterone,[mesh:D013739]
Binding of Influenza A Virus (IAV) to Sialic Acid Glycan Receptor leads to viral infection proliferation,506,Sialic Acid,[mesh:D019158]
XX Inhibition of Sodium Iodide Symporter and Subsequent Adverse Neurodevelopmental Outcomes in Mammals,65,Sodium Iodide,[mesh:D012974]
Xenobiotic Inhibition of Dopamine-beta-Hydroxylase and subsequent reduced fecundity,73,dopamine,[mesh:D004298]
Reactive Oxygen (ROS) formation leads to cancer via Peroxisome proliferation-activated receptor (PPAR) pathway,513,Oxygen,[mesh:D010100]
Reactive Oxygen (ROS) formation leads to cancer via Peroxisome proliferation-activated receptor (PPAR) pathway,513,peroxyl,[CHEBI:25935]
Reactive Oxygen (ROS) formation leads to cancer via Peroxisome proliferation-activated receptor (PPAR) pathway,513,superoxide,[mesh:D013481]
Reactive Oxygen (ROS) formation leads to cancer via Peroxisome proliferation-activated receptor (PPAR) pathway,513,ozone,[mesh:D010126]
Reactive Oxygen (ROS) formation leads to cancer via Peroxisome proliferation-activated receptor (PPAR) pathway,513,hydroxyl,[mesh:D017665]
Decreased ALDH1A (RALDH) activity leading to decreased fertility via disrupted meiotic initiation of fetal oogonia,398,retinoid,[CHEBI:4913]
Decreased ALDH1A (RALDH) activity leading to decreased fertility via disrupted meiotic initiation of fetal oogonia,398,all-trans retinoic acid,[mesh:D014212]
Oxygen-evolving complex damage leading to population decline via inhibition of photosynthesis,389,Oxygen,[mesh:D010100]
Oxygen-evolving complex damage leading to population decline via inhibition of photosynthesis,389,ATP,[CHEBI:30616]
"NR1I2 (Pregnane X Receptor, PXR)  activation leading to hepatic steatosis",60,Pregnane,[CHEBI:8386]
AOP for thyroid disorder caused by triphenyl phosphate via TRβ activation,393,triphenyl phosphate,[mesh:C005445]
AOP for thyroid disorder caused by triphenyl phosphate via TRβ activation,393,TPP,[CHEBI:35033]
AOP for thyroid disorder caused by triphenyl phosphate via TRβ activation,393,C,[CHEBI:30039]
Reduced availability of GnRH leading to uterine adenocarcinoma via increased estrogen availability at target organ level,512,Estrogen,[mesh:D004967]
"Increased (ectopic) concentration of all-trans retinoic acid (ATRA) if fetal testis leading to reduced sperm count, males",400,retinoic acid,[CHEBI:26536]
"Increased (ectopic) concentration of all-trans retinoic acid (ATRA) if fetal testis leading to reduced sperm count, males",400,all-trans retinoic acid,[mesh:D014212]
Cardiac ion channels blockade  leading to  increased incidence of cardiovascular morbidity and mortality,519,potassium,[mesh:D011188]
Liver X Receptor (LXR) activation leads to liver steatosis,518,Estrogen,[mesh:D004967]
Liver X Receptor (LXR) activation leads to liver steatosis,518,Pregnane,[CHEBI:8386]
Liver X Receptor (LXR) activation leads to liver steatosis,518,fatty acid,[mesh:D005227]
Liver X Receptor (LXR) activation leads to liver steatosis,518,triglycerides,[mesh:D014280]
Liver X Receptor (LXR) activation leads to liver steatosis,518,retinoic acid,[CHEBI:26536]
Liver X Receptor (LXR) activation leads to liver steatosis,518,Arhyl hydrocarbon,[CHEBI:27841]
Liver X Receptor (LXR) activation leads to liver steatosis,518,androstane,[CHEBI:35509]
Liver X Receptor (LXR) activation leads to liver steatosis,518,Farnesoid,[CHEBI:36756]
Retinoic acid receptor agonism during neurodevelopment leading to microcephaly,523,retinoic acid,[CHEBI:26536]
G protein-coupled estrogen receptor 1 (GPER) signal pathway in the lipid metabolism disrupting effects,401,Estrogen,[mesh:D004967]
G protein-coupled estrogen receptor 1 (GPER) signal pathway in the lipid metabolism disrupting effects,401,triphenyl phosphate,[mesh:C005445]
G protein-coupled estrogen receptor 1 (GPER) signal pathway in the lipid metabolism disrupting effects,401,TPP,[CHEBI:35033]
G protein-coupled estrogen receptor 1 (GPER) signal pathway in the lipid metabolism disrupting effects,401,triglycerides,[mesh:D014280]
G protein-coupled estrogen receptor 1 (GPER) signal pathway in the lipid metabolism disrupting effects,401,cholesterol,[mesh:D002784]
Thyroid peroxidase (TPO) inhibition leads to periventricular heterotopia formation in the developing rat brain,402,6-propylthiouracil,[CHEBI:8502]
Retinoic acid receptor agonism during neurodevelopment leading to impaired learning and memory,520,retinoic acid,[CHEBI:26536]
Essential element imbalance leads to reproductive failure via oxidative stress,521,Cd,[CHEBI:22977]
Essential element imbalance leads to reproductive failure via oxidative stress,521,cadmium,[mesh:D002104]
Frustrated phagocytosis leads to malignant mesothelioma,409,carbon,[mesh:D002244]
"Decreased Insulin-like peptide 3 (INSL3) leads to Malformation, cryptorchidism - maldescended testis",528,phthalate,[CHEBI:17563]
"Decreased Insulin-like peptide 3 (INSL3) leads to Malformation, cryptorchidism - maldescended testis",528,Androgen,[mesh:D000728]
"Decreased Insulin-like peptide 3 (INSL3) leads to Malformation, cryptorchidism - maldescended testis",528,testosterone,[mesh:D013739]
"Decreased Insulin-like peptide 3 (INSL3) leads to Malformation, cryptorchidism - maldescended testis",528,phthalates,[mesh:C032279]
"Decreased, Chicken Ovalbumin Upstream Promoter Transcription Factor II (COUP-TFII) leads to Hypospadias, increased",527,phthalate,[CHEBI:17563]
"Decreased, Chicken Ovalbumin Upstream Promoter Transcription Factor II (COUP-TFII) leads to Hypospadias, increased",527,Androgen,[mesh:D000728]
"Decreased, Chicken Ovalbumin Upstream Promoter Transcription Factor II (COUP-TFII) leads to Hypospadias, increased",527,5-alpha-dihydrotestosterone,[mesh:D013196]
"Decreased, Chicken Ovalbumin Upstream Promoter Transcription Factor II (COUP-TFII) leads to Hypospadias, increased",527,phthalates,[mesh:C032279]
Modulation of Adult Leydig Cell Function Subsequent to Glucocorticoid Activation,71,testosterone,[mesh:D013739]
"Decreased, Chicken Ovalbumin Upstream Promoter Transcription Factor II (COUP-TFII) leads to Impaired, Spermatogenesis",526,phthalate,[CHEBI:17563]
"Decreased, Chicken Ovalbumin Upstream Promoter Transcription Factor II (COUP-TFII) leads to Impaired, Spermatogenesis",526,Androgen,[mesh:D000728]
"Decreased, Chicken Ovalbumin Upstream Promoter Transcription Factor II (COUP-TFII) leads to Impaired, Spermatogenesis",526,testosterone,[mesh:D013739]
"Decreased, Chicken Ovalbumin Upstream Promoter Transcription Factor II (COUP-TFII) leads to Impaired, Spermatogenesis",526,phthalates,[mesh:C032279]
SARS-CoV-2 infection leading to hyperinflammation,406,Oxygen,[mesh:D010100]
SARS-CoV-2 infection leading to hyperinflammation,406,superoxide,[mesh:D013481]
Imbalance in redox homeostasis leading to structural damage to tissues,408,Graphene,[mesh:D006108]
Imbalance in redox homeostasis leading to structural damage to tissues,408,Triphenyl,[CHEBI:33080]
Retinoic acid receptor antagonism during neurodevelopment leading to impaired learning and memory,533,retinoic acid,[CHEBI:26536]
Aryl hydrocarbon receptor activation leading to impaired lung function through P53 toxicity pathway,419,aryl hydrocarbon,[mesh:D006841]
Retinoic acid receptor agonism during cerebellar development leading to impaired locomotor function,532,retinoic acid,[CHEBI:26536]
Aryl hydrocarbon receptor activation leading to lung cancer through AHR-ARNT toxicity pathway,417,aryl hydrocarbon,[mesh:D006841]
Aryl hydrocarbon receptor activation leading to lung fibrosis through IL-6 toxicity pathway,415,aryl hydrocarbon,[mesh:D006841]
Aryl hydrocarbon receptor activation leading to lung cancer through IL-6 toxicity pathway,416,aryl hydrocarbon,[mesh:D006841]
Oxidation and antagonism of reduced glutathione leading to mortality via acute renal failure,413,Oxygen,[mesh:D010100]
Oxidation and antagonism of reduced glutathione leading to mortality via acute renal failure,413,glutathione,[CHEBI:57925]
Oxidation and antagonism of reduced glutathione leading to mortality via acute renal failure,413,uranium,[mesh:D014501]
Oxidation and antagonism of reduced glutathione leading to mortality via acute renal failure,413,GSH,[mesh:D005978]
Binding and activation of GPER leading to learning and memory impairments,535,Estrogen,[mesh:D004967]
Binding and activation of GPER leading to learning and memory impairments,535,Bisphenol A,[mesh:C006780]
Binding and activation of GPER leading to learning and memory impairments,535,BPA,[CHEBI:33216]
Binding and activation of GPER leading to learning and memory impairments,535,Ca2+,[CHEBI:29108]
Binding and activation of GPER leading to learning and memory impairments,535,aryl hydrocarbon,[mesh:D006841]
Aryl hydrocarbon receptor activation leading to lung fibrosis through TGF-β dependent fibrosis toxicity pathway,414,aryl hydrocarbon,[mesh:D006841]
Succinate dehydrogenase (SDH) inhibition leads to cancer through oxidative stress,534,Oxygen,[mesh:D010100]
Succinate dehydrogenase (SDH) inhibition leads to cancer through oxidative stress,534,fumarate,[CHEBI:29806]
Succinate dehydrogenase (SDH) inhibition leads to cancer through oxidative stress,534,Succinate,[mesh:D019802]
Succinate dehydrogenase (SDH) inhibition leads to cancer through oxidative stress,534,ubiquinone,[mesh:D014451]
Succinate dehydrogenase (SDH) inhibition leads to cancer through oxidative stress,534,Calcium,[mesh:D002118]
Toxicological mechanisms of hepatocyte apoptosis through the PARP1 dependent cell death pathway,423,triphenyl phosphate,[mesh:C005445]
Toxicological mechanisms of hepatocyte apoptosis through the PARP1 dependent cell death pathway,423,TPP,[CHEBI:35033]
Toxicological mechanisms of hepatocyte apoptosis through the PARP1 dependent cell death pathway,423,organophosphate,[mesh:D010755]
Adverse outcome pathway of PFAS-induced vascular disrupting effects  via activating oxidative stress related pathways,538,Perfluorinated,[mesh:D006858]
Adverse outcome pathway of PFAS-induced vascular disrupting effects  via activating oxidative stress related pathways,538,polyfluoroalkyl,[CHEBI:53314]
Adverse outcome pathway of PFAS-induced vascular disrupting effects  via activating oxidative stress related pathways,538,fluorine,[mesh:D005461]
Adverse outcome pathway of PFAS-induced vascular disrupting effects  via activating oxidative stress related pathways,538,PFAS,[CHEBI:53371]
Aryl hydrocarbon receptor activation leading to lung cancer through sustained NRF2 toxicity pathway,420,aryl hydrocarbon,[mesh:D006841]
Estrogen receptor agonism leading to reduced survival and population growth due to renal failure,536,Estrogen,[mesh:D004967]
Estrogen receptor agonism leading to reduced survival and population growth due to renal failure,536,estradiol,[CHEBI:16469]
Estrogen receptor agonism leading to reduced survival and population growth due to renal failure,536,polychlorinated biphenyls,[CHEBI:53156]
Estrogen receptor agonism leading to reduced survival and population growth due to renal failure,536,ethinylestradiol,[mesh:D004997]
Estrogen receptor agonism leading to reduced survival and population growth due to renal failure,536,EE2,[CHEBI:46616]
Estrogen receptor agonism leading to reduced survival and population growth due to renal failure,536,polycyclic aromatic hydrocarbons,[mesh:D011084]
Estrogen receptor agonism leading to reduced survival and population growth due to renal failure,536,phenolic,[CHEBI:15882]
Estrogen receptor agonism leading to reduced survival and population growth due to renal failure,536,alkylphenols,[CHEBI:38976]
Estrogen receptor agonism leading to reduced survival and population growth due to renal failure,536,parabens,[mesh:D010226]
Estrogen receptor agonism leading to reduced survival and population growth due to renal failure,536,FC10-diol,[mesh:C546883]
Estrogen receptor agonism leading to reduced survival and population growth due to renal failure,536,3-diol,[CHEBI:23824]
Estrogen receptor agonism leading to reduced survival and population growth due to renal failure,536,sterol,[mesh:D013261]
Estrogen receptor agonism leading to reduced survival and population growth due to renal failure,536,phthalates,[mesh:C032279]
Oxidative Stress in the Fish Ovary Leads to Reproductive Impairment via Reduced Vitellogenin Production,540,estradiol,[CHEBI:16469]
Oxidative Stress in the Fish Ovary Leads to Reproductive Impairment via Reduced Vitellogenin Production,540,Oxygen,[mesh:D010100]
Decreased Sodium/Potassium ATPase activity leads to Heart failure,539,Na+,[CHEBI:29101]
Decreased Sodium/Potassium ATPase activity leads to Heart failure,539,K+,[CHEBI:29103]
Decreased Sodium/Potassium ATPase activity leads to Heart failure,539,Copper,[mesh:D003300]
Decreased Sodium/Potassium ATPase activity leads to Heart failure,539,Sodium,[mesh:D012964]
Decreased Sodium/Potassium ATPase activity leads to Heart failure,539,potassium,[mesh:D011188]
Oxidative stress Leading to Decreased Lung Function via CFTR dysfunction,424,cAMP,[mesh:D000242]
Oxidative stress Leading to Decreased Lung Function via CFTR dysfunction,424,Cl,[CHEBI:30120]
Oxidative stress Leading to Decreased Lung Function via CFTR dysfunction,424,ozone,[mesh:D010126]
Inhibition of neuropathy target esterase leading to delayed neuropathy via lysolecithin cell membrane integration,543,lysolecithin,[mesh:D008244]
Inhibition of neuropathy target esterase leading to delayed neuropathy via lysolecithin cell membrane integration,543,organophosphate,[mesh:D010755]
Increased tumor necrosis factor (TNF) leading to increased risk of gestational diabetes mellitus (GDM),431,glucose,[CHEBI:42758]
Increased tumor necrosis factor (TNF) leading to increased risk of gestational diabetes mellitus (GDM),431,DEHP,[mesh:D004051]
"Activation, Pregnane-X receptor, NR1l2 leads to increased plasma low-density lipoprotein (LDL) cholesterol via increased cholesterol synthesis",545,Pregnane,[CHEBI:8386]
"Activation, Pregnane-X receptor, NR1l2 leads to increased plasma low-density lipoprotein (LDL) cholesterol via increased cholesterol synthesis",545,glucose,[CHEBI:42758]
"Activation, Pregnane-X receptor, NR1l2 leads to increased plasma low-density lipoprotein (LDL) cholesterol via increased cholesterol synthesis",545,steroid,[mesh:D013256]
"Activation, Pregnane-X receptor, NR1l2 leads to increased plasma low-density lipoprotein (LDL) cholesterol via increased cholesterol synthesis",545,sterol,[mesh:D013261]
"Activation, Pregnane-X receptor, NR1l2 leads to increased plasma low-density lipoprotein (LDL) cholesterol via increased cholesterol synthesis",545,retinoid,[CHEBI:4913]
"Activation, Pregnane-X receptor, NR1l2 leads to increased plasma low-density lipoprotein (LDL) cholesterol via increased cholesterol synthesis",545,cholesterol,[mesh:D002784]
Binding of S-protein to ACE2 in enterocytes induces ACE2 dysregulation leading to gut dysbiosis,428,amino acids,[mesh:D000596]
Binding of S-protein to ACE2 in enterocytes induces ACE2 dysregulation leading to gut dysbiosis,428,tryptophan,[mesh:D014364]
Inhibition of neuropathy target esterase leading to delayed neuropathy via increased inflammation,544,organophosphate,[mesh:D010755]
A cholesterol/glucose dysmetabolism initiated Tau-driven AOP toward memory loss (AO) in sporadic Alzheimer's Disease with plausible MIE's plug-ins for environmental neurotoxicants,429,glucose,[CHEBI:42758]
A cholesterol/glucose dysmetabolism initiated Tau-driven AOP toward memory loss (AO) in sporadic Alzheimer's Disease with plausible MIE's plug-ins for environmental neurotoxicants,429,cholesterol,[mesh:D002784]
Hypothalamus estrogen receptors activity suppression leading to ovarian cancer via ovarian epithelial cell hyperplasia,440,Estrogen,[mesh:D004967]
Hypothalamus estrogen receptors activity suppression leading to ovarian cancer via ovarian epithelial cell hyperplasia,440,estradiol,[CHEBI:16469]
Hypothalamus estrogen receptors activity suppression leading to ovarian cancer via ovarian epithelial cell hyperplasia,440,testosterone,[mesh:D013739]
Hypothalamus estrogen receptors activity suppression leading to ovarian cancer via ovarian epithelial cell hyperplasia,440,steroid,[mesh:D013256]
Hypothalamus estrogen receptors activity suppression leading to ovarian cancer via ovarian epithelial cell hyperplasia,440,estrone,[mesh:D004970]
Hypothalamus estrogen receptors activity suppression leading to ovarian cancer via ovarian epithelial cell hyperplasia,440,clomiphene citrate,[CHEBI:3753]
Hypothalamus estrogen receptors activity suppression leading to ovarian cancer via ovarian epithelial cell hyperplasia,440,Tamoxifen,[mesh:D013629]
Hypothalamus estrogen receptors activity suppression leading to ovarian cancer via ovarian epithelial cell hyperplasia,440,Toremifene,[mesh:D017312]
Hypothalamus estrogen receptors activity suppression leading to ovarian cancer via ovarian epithelial cell hyperplasia,440,progesterone,[mesh:D011374]
Hypothalamus estrogen receptors activity suppression leading to ovarian cancer via ovarian epithelial cell hyperplasia,440,cholesterol,[mesh:D002784]
reactive oxygen species generation leading to increased cardiovascular morbidity and mortality,438,Oxygen,[mesh:D010100]
Androgen receptor agonism leading to long anogenital distance in female offspring,547,Androgen,[mesh:D000728]
Succinate dehydrogenase inactivation leads to cancer through hypoxic-like mechanisms,546,Oxygen,[mesh:D010100]
Succinate dehydrogenase inactivation leads to cancer through hypoxic-like mechanisms,546,fumarate,[CHEBI:29806]
Succinate dehydrogenase inactivation leads to cancer through hypoxic-like mechanisms,546,Succinate,[mesh:D019802]
Succinate dehydrogenase inactivation leads to cancer through hypoxic-like mechanisms,546,ubiquinone,[mesh:D014451]
Succinate dehydrogenase inactivation leads to cancer through hypoxic-like mechanisms,546,Prolyl,[CHEBI:26274]
Succinate dehydrogenase inactivation leads to cancer through hypoxic-like mechanisms,546,Calcium,[mesh:D002118]
hERG channel blockade leading to sudden cardiac death,433,potassium,[mesh:D011188]
Na+ /K+ -ATPase inhibition leading to hypertension,516,Na+,[CHEBI:29101]
Na+ /K+ -ATPase inhibition leading to hypertension,516,K+,[CHEBI:29103]
Nicotinic acetylcholine receptor activation contributes to abnormal foraging and leads to colony loss/failure,87,acetylcholine,[mesh:D000109]
"Inhibition, Ether-a-go-go (ERG) Voltage-Gated Potassium Channel leading to heart failure",555,potassium,[mesh:D011188]
"Inhibition, Ether-a-go-go (ERG) Voltage-Gated Potassium Channel leading to heart failure",555,sotalol,[mesh:D013015]
"Inhibition, Ether-a-go-go (ERG) Voltage-Gated Potassium Channel leading to heart failure",555,amiodarone,[mesh:D000638]
"Inhibition, Ether-a-go-go (ERG) Voltage-Gated Potassium Channel leading to heart failure",555,dofetilide,[mesh:C063533]
"Inhibition, Ether-a-go-go (ERG) Voltage-Gated Potassium Channel leading to heart failure",555,Calcium,[mesh:D002118]
CYP26 inhibition leading to disturbed dorsal lateral hinge point bending which causes neural tube closure defects,434,zinc,[CHEBI:30185]
CYP26 inhibition leading to disturbed dorsal lateral hinge point bending which causes neural tube closure defects,434,ZIC3,[CHEBI:27007]
CYP26 inhibition leading to disturbed dorsal lateral hinge point bending which causes neural tube closure defects,434,retinol,[mesh:D014801]
CYP26 inhibition leading to disturbed dorsal lateral hinge point bending which causes neural tube closure defects,434,all-trans retinoic acid,[mesh:D014212]
Inhibition of Voltage-gated sodium channels (Na⁺ channels)  leading to heart failure,553,Na+,[CHEBI:29101]
Inhibition of Voltage-gated sodium channels (Na⁺ channels)  leading to heart failure,553,Sodium,[mesh:D012964]
Inhibition of Voltage-gated sodium channels (Na⁺ channels)  leading to heart failure,553,Calcium,[mesh:D002118]
β-adrenergic receptor agonists leading to arrhythmias.,554,cAMP,[mesh:D000242]
β-adrenergic receptor agonists leading to arrhythmias.,554,ryanodine,[mesh:D012433]
β-adrenergic receptor agonists leading to arrhythmias.,554,catecholamine,[mesh:D002395]
β-adrenergic receptor agonists leading to arrhythmias.,554,Calcium,[mesh:D002118]
"Activation, Pregnane-X receptor, NR1l2 leads to increased plasma low-density lipoprotein (LDL) cholesterol via increased PCSK9 protein expression",548,Pregnane,[CHEBI:8386]
"Activation, Pregnane-X receptor, NR1l2 leads to increased plasma low-density lipoprotein (LDL) cholesterol via increased PCSK9 protein expression",548,glucose,[CHEBI:42758]
"Activation, Pregnane-X receptor, NR1l2 leads to increased plasma low-density lipoprotein (LDL) cholesterol via increased PCSK9 protein expression",548,steroid,[mesh:D013256]
"Activation, Pregnane-X receptor, NR1l2 leads to increased plasma low-density lipoprotein (LDL) cholesterol via increased PCSK9 protein expression",548,sterol,[mesh:D013261]
"Activation, Pregnane-X receptor, NR1l2 leads to increased plasma low-density lipoprotein (LDL) cholesterol via increased PCSK9 protein expression",548,cholesterol,[mesh:D002784]
Demethylation of PPAR promotor leading to vascular disrupting effects,510,nitric oxide,[mesh:D009569]
Janus kinase (JAK)/Signal transducer and activator of transcription (STAT) and Transforming growth factor (TGF)-beta pathways activation leading to reproductive failure,208,TiO2,[CHEBI:32234]
Janus kinase (JAK)/Signal transducer and activator of transcription (STAT) and Transforming growth factor (TGF)-beta pathways activation leading to reproductive failure,208,TiO2NPs,[CHEBI:51050]
Janus kinase (JAK)/Signal transducer and activator of transcription (STAT) and Transforming growth factor (TGF)-beta pathways activation leading to reproductive failure,208,Titanium dioxide,[mesh:C009495]
Increased LMNA gene mutation leading to heart failure,550,Oxygen,[mesh:D010100]
Increased Muscarinic M2 Receptor leading to Arrhythmia,551,acetylcholine,[mesh:D000109]
Increased Muscarinic M2 Receptor leading to Arrhythmia,551,organophosphate,[mesh:D010755]
"Inhibition of iNOS, hepatotoxicity, and regenerative proliferation leading to liver tumors",32,neonicotinoid,[mesh:D000073943]
"Inhibition of iNOS, hepatotoxicity, and regenerative proliferation leading to liver tumors",32,Thiamethoxam,[mesh:D000077922]
"Inhibition of iNOS, hepatotoxicity, and regenerative proliferation leading to liver tumors",32,CGA 330050,[CHEBI:39299]
"Inhibition of iNOS, hepatotoxicity, and regenerative proliferation leading to liver tumors",32,CGA 265307,[mesh:C471807]
"Inhibition of iNOS, hepatotoxicity, and regenerative proliferation leading to liver tumors",32,nitric oxide,[mesh:D009569]
"Inhibition of iNOS, hepatotoxicity, and regenerative proliferation leading to liver tumors",32,CGA 322704,[CHEBI:73178]
"Inhibition of iNOS, hepatotoxicity, and regenerative proliferation leading to liver tumors",32,thiamethoxams,[CHEBI:39185]
"Inhibition of iNOS, hepatotoxicity, and regenerative proliferation leading to liver tumors",32,cholesterol,[mesh:D002784]
Inhibiton of L-Type Calcium Channels leading to heart failure via QT interval prolongation and Torsades de Pointes (TdP),552,Calcium,[mesh:D002118]
Binding to voltage gate sodium channels during development leads to cognitive impairment,442,Sodium,[mesh:D012964]
Inhibition of Funny current (If) leading to Arrhythmias,560,nucleotides,[mesh:D009711]
Inhibition of Funny current (If) leading to Arrhythmias,560,ivabradine,[mesh:D000077550]
Inhibition of Funny current (If) leading to Arrhythmias,560,Na+,[CHEBI:29101]
Inhibition of Funny current (If) leading to Arrhythmias,560,K+,[CHEBI:29103]
Inhibition of Funny current (If) leading to Arrhythmias,560,Sodium,[mesh:D012964]
Inhibition of Funny current (If) leading to Arrhythmias,560,potassium,[mesh:D011188]
β2-Receptor agonist leading to Cardiomyopathy,557,catecholamine,[mesh:D002395]
β2-Receptor agonist leading to Cardiomyopathy,557,Calcium,[mesh:D002118]
Nicotinic acetylcholine receptor activation followed by desensitization contributes to abnormal foraging and directly leads to colony loss/failure,89,acetylcholine,[mesh:D000109]
Perturbation of cholesterol and glutathione homeostasis leading to hepatotoxicity: Integrated multi-OMICS approach for building AOP,209,glutathione,[CHEBI:57925]
Perturbation of cholesterol and glutathione homeostasis leading to hepatotoxicity: Integrated multi-OMICS approach for building AOP,209,S,[CHEBI:29832]
Perturbation of cholesterol and glutathione homeostasis leading to hepatotoxicity: Integrated multi-OMICS approach for building AOP,209,unsaturated fatty acid,[mesh:D005231]
Perturbation of cholesterol and glutathione homeostasis leading to hepatotoxicity: Integrated multi-OMICS approach for building AOP,209,sterol,[mesh:D013261]
Perturbation of cholesterol and glutathione homeostasis leading to hepatotoxicity: Integrated multi-OMICS approach for building AOP,209,cholesterol,[mesh:D002784]
Binding of Sars-CoV-2 spike protein to ACE 2 receptors expressed on brain cells (neuronal and non-neuronal) leads to neuroinflammation resulting in encephalitis,374,nitrogen,[mesh:D009584]
Binding of Sars-CoV-2 spike protein to ACE 2 receptors expressed on brain cells (neuronal and non-neuronal) leads to neuroinflammation resulting in encephalitis,374,Oxygen,[mesh:D010100]
Binding of Sars-CoV-2 spike protein to ACE 2 receptors expressed on brain cells (neuronal and non-neuronal) leads to neuroinflammation resulting in encephalitis,374,prostaglandin E2,[CHEBI:606564]
Binding of Sars-CoV-2 spike protein to ACE 2 receptors expressed on brain cells (neuronal and non-neuronal) leads to neuroinflammation resulting in encephalitis,374,nitric oxide,[mesh:D009569]
Phosphodiesterase inhibition leading to heart failure,558,nucleotides,[mesh:D009711]
Phosphodiesterase inhibition leading to heart failure,558,Oxygen,[mesh:D010100]
Phosphodiesterase inhibition leading to heart failure,558,cAMP,[mesh:D000242]
Phosphodiesterase inhibition leading to heart failure,558,cyclic GMP,[mesh:D006152]
Phosphodiesterase inhibition leading to heart failure,558,ryanodine,[mesh:D012433]
Phosphodiesterase inhibition leading to heart failure,558,Calcium,[mesh:D002118]
Estrogen Receptor Alpha Agonism leads to Impaired Reproduction,445,Estrogen,[mesh:D004967]
Estrogen Receptor Alpha Agonism leads to Impaired Reproduction,445,Androgen,[mesh:D000728]
Estrogen Receptor Alpha Agonism leads to Impaired Reproduction,445,steroid,[mesh:D013256]
Estrogen Receptor Alpha Agonism leads to Impaired Reproduction,445,progestin,[CHEBI:59826]
Inhibition of acetylcholinesterase (AChE) leading to arrhythmias,559,acetylcholine,[mesh:D000109]
Inhibition of acetylcholinesterase (AChE) leading to arrhythmias,559,Carbamate,[CHEBI:28616]
Inhibition of acetylcholinesterase (AChE) leading to arrhythmias,559,potassium,[mesh:D011188]
Inhibition of acetylcholinesterase (AChE) leading to arrhythmias,559,organophosphate,[mesh:D010755]
Decreased Na/K ATPase activity leading to heart failure,556,ATP,[CHEBI:30616]
Decreased Na/K ATPase activity leading to heart failure,556,Na+,[CHEBI:29101]
Decreased Na/K ATPase activity leading to heart failure,556,K+,[CHEBI:29103]
Decreased Na/K ATPase activity leading to heart failure,556,Sodium,[mesh:D012964]
Decreased Na/K ATPase activity leading to heart failure,556,potassium,[mesh:D011188]
Decreased Na/K ATPase activity leading to heart failure,556,Calcium,[mesh:D002118]